Abstracts, workshops and seminars from the Pandemic EVIDENCE Collaboration 2025 International Conference Published: 2026 I1 Foreword John Conly1,2, Ruth Davis3 1University of Calgary, Calgary, Canada; 2Kellogg College, University of Oxford, UK; 3Centre for Evidence -Based Medicine, University of Oxford, UK BMC Proceedings 2026, 20(29):I1 As noted on its website, (The Pandemic EVIDENCE Collaboration - Kellogg College), The Pandemic EVIDENCE Collaboration was “founded in 2023, with its official launch taking place in April 2024, funded by the McCall MacBain Foundation. It was a collaborative initiative launched by independent academics and scholars from top-tier institutions around the world. Participants included Bond University in Australia, the University of Calgary and McMaster University in Canada, Oslo Metropolitan University, and the University of Oxford in the UK. These experts united with a shared mission: to identify, develop, and implement strategies for generating high-quality evidence on Non Pharmacological Interventions (NPIs) during public health emergencies, with the aim of better informing policy and care decisions.” After more than a year of planning and agenda development, the Pandemic EVIDENCE Collaboration 2025 International Conference, entitled “Looking at the Pandemic in the Rearview Mirror: Successes, Failures and Unintended Consequences” was held May 14–16, 2025 at the Banff Centre for Arts and Creativity, in Banff, Canada in the heart of the Canadian Rockies. The themes of the Conference were aptly described in its title and was one of the first major international Conferences to systematically look back at the recent COVID-19 pandemic. The major aims of the Conference were to identify, develop and implement strategies to generate high-quality evidence for non-pharmacological interventions (NPIs) during public health emergencies to inform policy and care decisions. As described in the Annual Report (PEC-McCall-MacBain-Report-2024-2551.pdf), “the three-day conference featured daily themes aligned with the Pandemic Evidence Collaboration’s three pillars. Over 120 attendees from 13 countries were able to meet with and learn from high-profile international speakers in the field, and members of the collaboration were building connections [sic] and setting out potential future alliances.” A list of the Conference speakers is provided below and full details may be found on the Conference website. Banff conference event page - Kellogg College. Dr Oyuka Byambasuren, Institute for Evidence-Based Healthcare, Bond University, Australia Dr Ken Parhar, Cumming School of Medicine, University of Calgary, Canada Dr Atle Fretheim, Norwegian Institute of Public Health, Centre for Epidemic Interventions Research Professor Gordon Guyatt, Faculty of Health Sciences, McMaster University, Canada Dr David Evans, Dept of Medical Microbiology and Immunology Dept, University of Alberta, Canada Dr Annette Plüddemann, Centre for Evidence-Based Medicine, University of Oxford, UK Assistant Professor Jenine Leal, O’Brien Institute for Public Health, University of Calgary, Canada Professor Dominik Mertz, Faculty of Health Sciences, McMaster University, Canada Dr Mark Jones, Institute for Evidence-Based Healthcare, Bond University, Australia Dr Georgia Richards, King’s College London, UK Dr Lars Hemkens, University of Basel, Switzerland Dr Jessica Bartoszko, Faculty of Health Sciences, McMaster University, Canada Dr Sara Gandini, Department of Experimental Oncology in the European Institute of Oncology, Italy Dr Verna Yiu, Provost and Vice-President, University of Alberta, Canada Dr Ramona Ludolph, Epidemic and Pandemic Preparedness and Prevention Department, World Health Organization, Switzerland Dr Oyuka Byambasuren, Institute for Evidence-Based Healthcare, Bond University, Australia Dr Oyuka Byambasuren, Institute for Evidence-Based Healthcare, Bond University, Australia Dr Ken Parhar, Cumming School of Medicine, University of Calgary, Canada Dr Ken Parhar, Cumming School of Medicine, University of Calgary, Canada Dr Atle Fretheim, Norwegian Institute of Public Health, Centre for Epidemic Interventions Research Dr Atle Fretheim, Norwegian Institute of Public Health, Centre for Epidemic Interventions Research Professor Gordon Guyatt, Faculty of Health Sciences, McMaster University, Canada Professor Gordon Guyatt, Faculty of Health Sciences, McMaster University, Canada Dr David Evans, Dept of Medical Microbiology and Immunology Dept, University of Alberta, Canada Dr David Evans, Dept of Medical Microbiology and Immunology Dept, University of Alberta, Canada Dr Annette Plüddemann, Centre for Evidence-Based Medicine, University of Oxford, UK Dr Annette Plüddemann, Centre for Evidence-Based Medicine, University of Oxford, UK Assistant Professor Jenine Leal, O’Brien Institute for Public Health, University of Calgary, Canada Assistant Professor Jenine Leal, O’Brien Institute for Public Health, University of Calgary, Canada Professor Dominik Mertz, Faculty of Health Sciences, McMaster University, Canada Professor Dominik Mertz, Faculty of Health Sciences, McMaster University, Canada Dr Mark Jones, Institute for Evidence-Based Healthcare, Bond University, Australia Dr Mark Jones, Institute for Evidence-Based Healthcare, Bond University, Australia Dr Georgia Richards, King’s College London, UK Dr Georgia Richards, King’s College London, UK Dr Lars Hemkens, University of Basel, Switzerland Dr Lars Hemkens, University of Basel, Switzerland Dr Jessica Bartoszko, Faculty of Health Sciences, McMaster University, Canada Dr Jessica Bartoszko, Faculty of Health Sciences, McMaster University, Canada Dr Sara Gandini, Department of Experimental Oncology in the European Institute of Oncology, Italy Dr Sara Gandini, Department of Experimental Oncology in the European Institute of Oncology, Italy Dr Verna Yiu, Provost and Vice-President, University of Alberta, Canada Dr Verna Yiu, Provost and Vice-President, University of Alberta, Canada Dr Ramona Ludolph, Epidemic and Pandemic Preparedness and Prevention Department, World Health Organization, Switzerland Dr Ramona Ludolph, Epidemic and Pandemic Preparedness and Prevention Department, World Health Organization, Switzerland The full program from the International Conference in Banff is provided (Appendix A) along with a partial compilation of the peer reviewed accepted abstracts and descriptions of the workshops and seminars. The compilation represents only those presentations for which a response was received and permission was granted to do so from the designated registered presenting author(s). Brief editorial comments are provided at the end of each abstract or workshop/seminar description. 1 Effectiveness of non-pharmaceutical interventions as implemented in the UK during the COVID-19 pandemic: a rapid review of experimental, epidemiological and mathematical modelling studies Thulani Ashcroft1, Emilie McSwiggan1, Daphne Duval2, Serena Carville2, Stefano Brini2, Jose M. Ordonez-Mena3, Simon De Lusignan3, Aziz Sheikh3, Ruth McQuillan1, Evropi Theodoratou1 1University of Edinburgh, Edinburgh, UK; 2UKHSA, London, UK; 3University of Oxford, Oxford, UK BMC Proceedings 2026, 20(29):1 Background During the first year of the COVID-19 pandemic, NPIs were the only preventive methods available to governments, health systems and populations. They were mainly implemented as a combination of measures although the types of NPIs as well as how and when they were implemented varied across countries which makes the assessment of the evidence of individual NPIs challenging. We conducted a rapid review to assess the evidence on NPIs as implemented in the UK, to support policy-makers to prepare for future pandemics. Methods We systematically searched MEDLINE, EMBASE, NIH Covid Portfolio and Corona Central for all UK interventional, observational, and mathematical modelling studies published between March 2020 and January 2024 reporting on NPI effectiveness (as measured by COVID-19 cases, transmission, hospitalisation, and mortality). A modified synthesis without meta-analysis approach was taken to analyse the following domains for each NPI and outcome: methodological quality, study relevance, consistency of results across studies, and assessment of precision. Results Ninety-seven (85 modelling, nine observational, and three interventional) studies reported outcomes across 20 NPI categories. Modelling studies were limited by multiple quality issues, while only half of the non-modelling studies were high quality. Because of study heterogeneity, we synthesised the evidence on the direction, but not the size of effect. The evidence for test and release strategies for the contacts of positive cases (moderate certainty of evidence), school related NPIs (low certainty of evidence) and universal lockdown (low certainty of evidence) was suggestive of a protective effect. For the remaining NPI categories there was very low or inconclusive certainty of the evidence to support their effectiveness. Conclusions Our study was the first to assess the available evidence on the effectiveness of NPIs specifically as implemented in the UK. We found few studies with high internal validity, the rest were highly heterogeneous with most NPI categories providing very low certainty or inconclusive evidence of a protective effect. These results do not necessarily reflect a lack of effectiveness of packages of NPIs implemented in the UK but highlight the need to strengthen evaluation of public health interventions. We suggest strategies for improving evidence generation to support future pandemic decision-making. Editorial Comments: Accepted for Poster presentation. Pillar 2 - Interventions and Evidence 2 Randomized trials of public health and social measures for controlling pandemics: statistical challenges and opportunities Christopher James Rose, Unni Gopinathan, Runar Solberg Norwegian Institute of Public Health, Oslo, Norway BMC Proceedings 2026, 20(29):2 Before vaccines became available, public health and social measures (PHSM) such as mask mandates, school closures, social distancing, and restrictions on movement were the primary tools for managing the COVID-19 pandemic. However, these were implemented with limited high-quality evidence on their effects and interactions with respect to benefits and harms. To better prepare for future pandemics, there is a critical need for randomized PHSM trials to provide high-quality evidence for decision-making. PHSM trials face unique challenges compared to clinical trials for pharmaceuticals, vaccines, or other public health interventions. Parallel designs may not always satisfy ethics committees. Simple designs may be inefficient, risk exacerbating trial fatigue and recruitment difficulties, and can fail to represent diverse settings. Furthermore, trials of suboptimal dosing or implementation strategies may lead to misleading conclusions about PHSM safety and effectiveness. Common outcomes and effect measures, such as dichotomous events and risk ratios, may fail to capture the dynamic nature of infections and symptoms, limiting their utility to decision-makers. While PHSM trials should probably be pragmatic, their credibility can be undermined by nonadherence that differs from what would be expected during a pandemic, and missing outcome data. Addressing these issues could improve both the quality of the evidence and its broader acceptance. Misalignment between research questions and trial results could further limit the applicability of PHSM trials to future pandemics. Traditional reporting approaches, such as publishing a single effect estimate in a journal, may limit the utility of trial results for future pandemics and populations that differ from trial settings. This presentation will explore methodological options and innovations in trial design and powering, outcome selection and development, analysis and effect measures, and reporting, to address these challenges. It will also highlight research opportunities to advance PHSM trial methodology, ensuring the delivery of high-quality, translatable evidence that equips decision-makers to manage future pandemics effectively. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 – Interventions and Evidence 3 Side-effects of using lockdown as public health measure: impact of COVID-19 restrictions on violence against young girls and their mental health in Bhopal, Madhya Pradesh Rajnish Prasad IIHMR University, Jaipur, India BMC Proceedings 2026, 20(29):3 Background In response to the COVID-19 pandemic, governments worldwide implemented strict lockdown measures to control the spread of the COVID19. While considered important from public health perspective, these restrictions disproportionately impacted vulnerable populations, particularly in developing countries like India where social and gender norms increases the vulnerabilities faced by young girls. This study explores the compounded effects of the lockdown on violence against adolescent girls and mental health among adolescent girls in urban areas of Bhopal, India. Methods A mixed-methods approach was used, combining structured surveys of 256 adolescent girls aged 15–24 with qualitative insights from focus group discussions (FGDs) and in-depth interviews with 30 participants. Results The findings from study show that that 47% of girls faced some form of violence, with family’s income loss and movement restrictions as key drivers. Among young girls with partner, 69% girls reported increase in intimate partner violence, as social isolation exacerbated vulnerabilities by limiting access to support networks. Social isolation and movement restrictions also contributed in worsening of mental health among young girls, with 72% reported anxiety symptoms, 52% shown signs of depression, and 43% experienced sleep disturbances. Additional stressors, such as interrupted education, increased caregiving responsibilities, and the lack of psychosocial support, further compounded these challenges. During FGDs and in-depth interviews, girls shared that lockdowns have increased their care responsibilities and time spent on household work. Due to existing digital inequities, girls have much lesser access to mobile phone and internet which means they were not able to communicate with their friends and their education was also affected. Conclusions The findings highlight the lockdown’s role in exacerbating pre-existing gender inequalities, creating a “shadow pandemic” of violence and mental health crises. Immediate and long-term policy measures are necessary to address these compounded impacts. Further, while designing and implementing non-pharmacological interventions (NPIs) during public health emergencies it is very important to understand how these interventions will interact with existing inequities and vulnerabilities. The findings from the study underscores the critical need for an intersectional approach to policymaking that prioritizes the safety, mental health, and well-being of vulnerable groups including young girls, fostering resilience and equity. By addressing these vulnerabilities, policymakers can contribute to effective response to public health emergencies, ensuring that girls and women are not left behind in the wake of public health crises. Editorial Comments: Accepted for oral abstract presentation. Pillar 3 - Practice and Policy 4 Interventions to enable or improve evidence-informed decision-making in public health and preventive medicine practice: a scoping review Emily Groot1,2, Jessica Pelley1, Anne-Marie Boylan2, David Nunan2 1NOSM University, Sudbury, Canada; 2University of Oxford, Oxford, UK BMC Proceedings 2026, 20(29):4 Editorial Comments: Accepted for oral abstract presentation. Pillar 3 - Practice and Policy Currently published as a full manuscript and citation below: Groot E, Pelley J, Boylan AM, Nunan D. Interventions to Enable or Improve Evidence-Informed Decision Making in Public Health and Preventive Medicine: A Scoping Review. AJPM Focus. 2025 Dec 11;5(3):100473. https://doi.org/10.1016/j.focus.2025.100473https://pubmed.ncbi.nlm.nih.gov/41940210/ Groot E, Pelley J, Boylan AM, Nunan D. Interventions to Enable or Improve Evidence-Informed Decision Making in Public Health and Preventive Medicine: A Scoping Review. AJPM Focus. 2025 Dec 11;5(3):100473. https://doi.org/10.1016/j.focus.2025.100473https://pubmed.ncbi.nlm.nih.gov/41940210/ Groot E, Pelley J, Boylan AM, Nunan D. Interventions to Enable or Improve Evidence-Informed Decision Making in Public Health and Preventive Medicine: A Scoping Review. AJPM Focus. 2025 Dec 11;5(3):100473. https://doi.org/10.1016/j.focus.2025.100473https://pubmed.ncbi.nlm.nih.gov/41940210/ 5 Impact of the COVID-19 pandemic on adverse event incidence rates in Canadian hospitals: a retrospective chart review study Guosong Wu University of Calgary, Calgary, Canada BMC Proceedings 2026, 20(29):5 Objectives Tremendous efforts have been made to improve the quality and safety of healthcare in Canada. Yet, progress in addressing hospital adverse events has been varied and lacks comprehensive assessment. The study aimed to evaluate the incidence rates and trends of AEs, assess the impact of the COVID-19 pandemic on AE rates, and analyze differences in patient outcomes. Methods This retrospective electronic chart review included a random sample of adult patients admitted to acute care hospitals in Calgary between 2017 and 2022. Eighteen Aes and patient information was extracted. We calculated the observed adverse event incidence rates and risk-standardized adverse event rates (RSAER). Interrupted time series analysis was employed to determine the impact of COVID-19 on AE trends. Outcome differences were evaluated using mixed-effects logistic regression and negative binomial models. Results Among 10,673 patient admissions, 2,310 Aes were identified, resulting in an incidence rate of 21.64 (95% CI: 20.77–22.54) per 100 patient admissions, or 30.65 (95% CI: 25.77–27.97) per 1,000 patient days. Although a modest upward trend in AE rates was noted during the pandemic, statistical significance was not reached (IRR=1.13, 95% CI:0.74–1.75) after adjusting for patient characteristics, seasonal variations, and overall trends. In multivariable mixed-effect models, patients with Aes had significantly longer hospital stays (IRR=3.13, 95% CI: 2.97–3.30), increased odds of experiencing 30-day readmission (OR=1.4, 95% CI: 1.17–1.68) and in-hospital death (OR=1.72, 95% CI: 1.43–2.08). Conclusions The incidence of Aes remains high in acute healthcare settings. Despite the challenges posed by COVID-19, our study suggests that AE rates did not significantly increase. Future initiatives are needed to implement strategies and interventions to reduce adverse events in the post-pandemic era. Editorial Comments: Accepted for oral abstract presentation. Pillar 3 – Practice and Policy 6 Evaluation of the Norwegian national tool for observation of infection prevention measures in healthcare (NOST) – a cluster randomized trial Mette Fagernes1, Eriksen-Volle Hanne-Merete1, Christine Holst2, Christopher James Rose2,3, Runar Barstad Solberg2, Petter Elstrøm2 1Department of Infection control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway; 2Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway; 3Cluster for Reviews and Health Technology Assessments, Norwegian Institute of Public Health, Oslo, Norway BMC Proceedings 2026, 20(29):6 Introduction Hand hygiene is a crucial preventive measure in managing pandemics. Effective infection prevention and control (IPC) is essential for ensuring high-quality healthcare services. Healthcare-associated infections (HAIs) can disrupt essential medical treatments1. To prevent HAIs, healthcare personnel must adhere to standard IPC measures during patient care, including hand hygiene and the use of personal protective equipment. Although healthcare personnel may have high knowledge of proper hand hygiene practices, compliance can vary significantly between healthcare services and professional groups2. The Norwegian Institute of Public Health (NIPH) has introduced a new electronic tool and national template for direct observation of compliance with recommended IPC measures in healthcare (NOST). This abstract describes an ongoing cluster-randomized trial3 that aims to measure if the implementation of NOST leads to: 1) increased compliance with hand hygiene recommendations, and 2) impacts the epidemiology of HAIs in healthcare institutions and the length of hospital stays. Methods Eligible hospital wards were randomly allocated 1:1 to intervention or control. The intervention involves implementing NOST, which includes observing and recording compliance with hand hygiene recommendations, reporting the results back to the wards, identifying areas for improvement, followed by training and other measures to improve IPC. Implementation of NOST in control wards was delayed for one year, until after data collection had been completed. The primary outcome is compliance with hand hygiene recommendations by hospital staff performing patient-related work. Secondary outcomes include HAIs and length of hospital stays. Data were obtained from the national NOST database and Norwegian health registers. Treatment effects will be estimated as risk ratios or mean differences, depending on whether the outcome variables are binomial or continuous4. Results Data, including more than 3000 hand hygiene observations from 106 wards across 16 hospitals, were collected in November 2024 and will be analysed in the following months. We will present final or preliminary results at the Pandemic Evidence Collaboration conference in May 2025. Conclusions Ensuring high compliance with hand hygiene among healthcare personnel is crucial for maintaining the quality of healthcare services. During outbreaks and pandemics, maintaining good hand hygiene practices is essential. Our trial evaluates the effect of a tool for improving compliance with hand hygiene recommendations. Editorial Comments: Accepted for poster presentation. Pillar 2 - Interventions and Evidence References Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32(2): 101-14.Bredin D, O’Doherty D, Hannigan A, Kingston L. Hand hygiene compliance by direct observation in physicians and nurses: a systematic review and meta-analysis. J Hosp Infect 2022; 130: 20–33.Study protocol: Evaluation of the National tool for observation of infection prevention measures in the healthcare (NOST) – a cluster randomized trial. Zenodo. https://doi.org/10.5281/zenodo.7648821Statistical Analysis Plan: Evaluation of the National tool for observation of infection prevention measures in the healthcare (NOST) – a cluster randomized trial. Zenodo. https://doi.org/10.5281/zenodo.14012093 Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32(2): 101-14. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32(2): 101-14. Bredin D, O’Doherty D, Hannigan A, Kingston L. Hand hygiene compliance by direct observation in physicians and nurses: a systematic review and meta-analysis. J Hosp Infect 2022; 130: 20–33. Bredin D, O’Doherty D, Hannigan A, Kingston L. Hand hygiene compliance by direct observation in physicians and nurses: a systematic review and meta-analysis. J Hosp Infect 2022; 130: 20–33. Study protocol: Evaluation of the National tool for observation of infection prevention measures in the healthcare (NOST) – a cluster randomized trial. Zenodo. https://doi.org/10.5281/zenodo.7648821 Study protocol: Evaluation of the National tool for observation of infection prevention measures in the healthcare (NOST) – a cluster randomized trial. Zenodo. https://doi.org/10.5281/zenodo.7648821 Statistical Analysis Plan: Evaluation of the National tool for observation of infection prevention measures in the healthcare (NOST) – a cluster randomized trial. Zenodo. https://doi.org/10.5281/zenodo.14012093 Statistical Analysis Plan: Evaluation of the National tool for observation of infection prevention measures in the healthcare (NOST) – a cluster randomized trial. Zenodo. https://doi.org/10.5281/zenodo.14012093 7 Use of technology in pandemic’s response – benefits and limitations: some insights from adaptation of CoWIN platform for COVID19 vaccination in India Rajnish Prasad IIHMR University, Jaipur, India BMC Proceedings 2026, 20(29):7 Objectives The global COVID-19 pandemic underscored the critical role of digital technologies in enabling large-scale public health responses. India’s CoWIN platform, a cornerstone of the world’s largest vaccination program, demonstrated how digital tools can streamline logistics, monitor coverage, and enhance transparency. By facilitating over 2 billion vaccinations, CoWIN highlighted the potential of technology to address complex public health challenges. However, it also revealed significant inequities, particularly in resource-limited settings. This paper examines the dual role of the use of CoWIN platform in advancing vaccine access while inadvertently amplifying existing disparities in health equity. Methods A comprehensive review was conducted using data available on CoWIN dashboard to analyze the uptake of COVID19 vaccination. Further, 26 in-depth interviews were conducted, to understand views of different stakeholders and beneficiaries. Results While the CoWIN app improved logistics in urban centers, rural areas with limited digital literacy and internet penetration were disproportionately affected. By May 2021, urban areas received 30 vaccine doses for every 12.7 doses administered in rural India, underscoring the digital divide in healthcare delivery. The exclusionary impact of digital-only channels is further amplified for populations without smartphones, stable internet connections, or the digital literacy needed to navigate such platforms. Gender inequities were particularly stark, with over 100 million women failing to receive their second vaccine dose by mid-2022. Besides that, linguistic barriers, inadequate offline systems, and limited health infrastructure emerged as significant obstacles to equitable vaccine distribution. Conclusions The findings from the study show that while digital tools can improve efficiency and scalability, its success depends on addressing structural inequities. Policymakers must prioritize inclusive design, multi-modal delivery, and proactive measures to bridge the digital divide. These principles are crucial to ensure that public health technologies promote equity and resilience in global health systems, particularly in the context of pandemic preparedness and response. Editorial Comments: Accepted for Elevator Pitch and poster presentation. Pillar 3 - Practice and Policy 8 Emergency preparedness and integrated surveillance potential of a rapid COVID-19 and TB diagnostic in Bangladesh: an adaptive response in health system governance Farzana Zaman1,2, Muhammad Asaduzzaman3 1Directorate General of Health Services (DGHS), Dhaka, Bangladesh; 2University of Pretoria, Pretoria, South Africa; 3University of Oslo, Oslo, Norway BMC Proceedings 2026, 20(29):8 Background The impact of the COVID-19 situation, coupled with the continual emergence of new variants, had significantly disrupted not only the local health system but also the aviation system and global public health. Subsequently, many unprecedented challenges have been observed at the health system management of resource poor settings, notably inadequate airport quarantine facilities and lack of highly sensitive yet rapid and cost-effective testing. Therefore, we aimed to present a cost-effective and timely alternative diagnostic and quarantine facility for the incoming travelers in such settings. Methods We conducted a cross-sectional serosurvey from December 15, 2020 to November 30, 2021 for inbound travelers to Bangladesh from different countries. These impoverished travelers (unable to afford hotel quarantine) were quarantined in Hajj camp (a government facility near the airport reserved for Muslim pilgrims) with full coverage of food and lodging at subsidized cost nd free testing by GeneXpert, which is capable of Nucleic Acid Amplification Test (NAAT) for both COVID-19 and TB. Results The majority of our study participants were male (74.32%), mainly in the 20–40 year age group. Among 1328 participants, 106 (7.98%) tested positive for SARS-COV-2, with 72 being male. The highest infection rate was observed in travelers from Singapore (22.53%, n=16/71), followed by USA and Malaysia. The NAAT result processing time was only 1 h, enabling 92% (1222 participants) to travel to their destinations on the same day. The positive cases were kept in quarantine for further assessment. Conclusions Our study findings endorse the equitable access to COVID-19 diagnostics for disadvantaged groups and optimizing the effective utilization of limited health system resources. Due to high sensitivity and specificity, NAAT is also recommended by WHO for diagnosis of acute COVID-19 cases. Therefore, our research also emphasizes on the potential to equip hard to reach laboratory facilities by GeneXpert for both TB and COVID-19 diagnostics to ensure fair and sustainable health systems, particularly in regions facing the dual burden. Editorial Comments: Accepted for oral abstract presentation. Pillar 3 - Practice and Policy 9 Antibiotic consumption and its link to the exaggeration of COVID-19 Muhammad Asaduzzaman1, Farzana Zaman2 1University of Oslo, Oslo, Norway; 2Directorate General of Health Services (DGHS), Dhaka, Bangladesh BMC Proceedings 2026, 20(29):9 When we observe the history of the deadliest pandemics on earth from Antonine Plague to current COVID-19(Forum, 2020), no bacterial pandemic has occurred since the discovery of Penicillin (Lobanovska & Pilla, 2017). The misuse of antibiotics in respiratory viral infections is well established (Li et al., 2016). We hypothesize that use of antibiotics is linked with the exacerbation of viral infections like COVID-19 on the basis of epidemiological and immunological evidence. Eili Y. Klein et al (2018) shows that United States, France, and Italy consumed the highest quantity of antibiotics among high income countries in 2015, while India, China, and Pakistan did it among lower middle-income countries. Surprisingly, these countries are also burdened with high COVID-19 cases (ECDC, 2020). Turkey, Tunisia, Spain, Greece, Algeria, Romania, Belgium, France, New Zealand and Ireland were the leading 10 countries for antibiotic use in total (Klein et al., 2018) and they are the countries with high disease prevalence (ECDC, 2020). Brazil is the leading country for antibiotic consumption (Klein et al., 2018) and same for COVID-19 cases (ECDC, 2020) in Latin America. The total antibiotic consumption (in metric tons) was higher in Brazil, Turkey, Iran, Russia, France, Tanzania, Sudan, Italy, UK and South Korea chronologically (WHO, 2018). We all are aware of the deadliest attack of current pandemic in these countries. In the ECDC report, the most COVID prevalent Spain, France, Italy, Ireland, Belgium, Portugal, Poland, UK are also listed as high antibiotic users in Europe (ECDC, 2019, 2020). Thackray et al (2018) have identified impaired T cell response and enhanced viral burden in response to flavi viruses (Dengue, Zika and West Nile virus) in mice after giving oral antibiotics including the ability of oral antibiotics (e.g. Ampicillin) to increase disease severity just with 3 days’ dose. Morbid COVID-19 patients develop a hyper inflammatory state alled the “Cytokine storm syndrome” with the increased production of proinflammatory cytokines like IL1β, IFNγ, TNF-α (Huang et al., 2020). We consider this type of immune response can be associated with antibiotic therapy. Antibiotics like Linezolid and Vancomycin can augment cytokine production (TNFα, IL-1β, IL-6, IL-10) through activating Toll-like receptors (Bode et al., 2015). Again, gut microbiota can halt the respiratory RNA virus replication in the lung epithelia through increased type 1 interferon signaling which can be delayed or severely hindered by antibiotics through reducing interferon-stimulated genes (ISGs) in lung stroma (Bradley et al., 2019). Our hypothesis is further supported by a recently published article (Hantoushzadeh & Norooznezhad,2020) where the authors have described the possible pathophysiology of antibiotic induced septic shock in COVID-19 patients. In the absence of bacterial infection if antibiotics are administered, the cytokine storm may initiate with unregulated release of Toll-like receptors (TLRs), IL-1β, IL-6, and TNF-α and gut endotoxins (Hantoushzadeh & Norooznezhad, 2020). Despite having several other factors, the fatality in SARS-CoV-2 infection is higher in European and high income countries where antibiotic consumption is higher. We recommend the containment of irrational use of antibiotics especially for respiratory symptoms in this pandemic era. Objectives When we observe the history of the deadliest pandemics on earth from Antonine Plague to current COVID-19, no bacterial pandemic has occurred since the discovery of Penicillin. The misuse of antibiotics in respiratory viral infections is well established. Therefore, we need to know whether the use of antibiotics is linked with the exacerbation of viral infections like COVID-19 on the basis of epidemiological and immunological evidence. Methods We conducted several biomedical resources including literature to identify the link between antibiotic consumption and COVID-19 mortality and morbidity. Results Impaired T cell response and viral burden is enhanced in mice after giving oral antibiotics including the ability of oral antibiotics to increase disease severity just with 3 days’ dose. Morbid COVID-19 patients develop a hyper inflammatory state called the “Cytokine storm syndrome” with the increased production of proinflammatory cytokines like IL1β, IFNγ, TNF-α. We consider this type of immune response can be associated with antibiotic therapy. Antibiotics like Linezolid and Vancomycin can augment cytokine production (TNFα, IL-1β, IL-6, IL-10) through activating Toll-like receptors. Again, gut microbiota can halt the respiratory RNA virus replication in the lung epithelia through increased type 1 interferon signaling which can be delayed or severely hindered by antibiotics through reducing interferon-stimulated genes (ISGs) in lung stroma. In the absence of bacterial infection if antibiotics are administered, the cytokine storm may initiate with unregulated release of Toll-like receptors (TLRs), IL-1β, IL-6, and TNF-α and gut endotoxins. Conclusions Despite having several other factors, the fatality in SARS-CoV-2 infection is higher in European and high income countries where antibiotic consumption is higher. We recommend the containment of irrational use of antibiotics especially for respiratory symptoms in this pandemic era. Editorial Comments: Accepted for Elevator Poster Pitch presentation. Pillar 2 – Interventions and Evidence 10 Exploring Norwegian public attitudes towards public health policy experiments in and outside of public health crises Ingeborg Hess Elgersma1, Unni Gopinathan1, Heather Munthe-Kaas1, Christine Holst1, Atle Fretheim1,2 1Norwegian Institute of Public Health, Oslo, Norway; 2Oslo Metropolitan University, Oslo, Norway BMC Proceedings 2026, 20(29):10 Background During the COVID-19 pandemic extensive non-pharmacological interventions (NPIs) were enforced that heavily impacted people’s lives. While the effectiveness of these interventions was often uncertain, authorities rarely initiated randomised implementation of these interventions (“policy experiments”). Public acceptance of public health policy experiments may be a barrier to generating high-quality evidence for NPIs. Objectives The objective of this study is to better understand Norwegian adults’ preferences regarding government-initiated public health policy experiments.The specific aims are to (1) Assess the general level of acceptability for public health policy experimentation among Norwegian adults; (2) Examine whether acceptance differs between trials (a) focused on different type of public health policies and (b) between trials conducted during and outside a pandemic; (3)Identify the conditions that increase or decrease public support for policy experiments during a pandemic and (4) Examine whether the level of acceptance differs between different types of trial design. Methods First, we will identify relevant stakeholders, such as policy advisors in the Ministry for Health, and involve them in defining scenarios for public health policy experiments. We will then recruit participants from the Norwegian Institute of Public Health (NIPH) panel (a panel of citizens who have consented to be invited to online trials). Participants will be randomly invited to one of several surveys exploring acceptance, attitudes toward, preferences and values connected to public health policy experiments. We conduct multiple surveys so that we can test whether how the scenarios for public health policy experiments are presented affect acceptability. In each survey, respondents will be asked to rate the acceptability of public authorities implementing the public health policy universally or conducting a policy experiment. We hypothesise that the public does not consider policy experimentation to be worse than what they rate the least acceptable policy alternative to be. Finally, we hypothesize that members of the NIPH public panel, who have consented to trial invitations, will show greater acceptance of experimentation than the general public. We will therefore compare their responses with those from an additional representative sample of the Norwegian population. Results The study will provide insight into public perceptions of public health policy experiments in Norway. Key findings will include general acceptance levels, attitudinal differences based on policy types and contexts (pandemic vs. non-pandemic), and determinants influencing public support for policy experimentation. Conclusions Understanding determinants of public attitudes towards public health policy experiments is essential for informing policymakers on how to increase public support and acceptance, which in turn can enable high-quality studies on the effects of NPIs. Editorial Comments: Accepted for oral abstract presentation. Pillar 3 - Practice and Policy 11 A scoping review of COVID-19 and other vaccination models for refugees and migrants Fariba Aghajafari1, Dorota Guzek Guzek2, Huzaifa Kamal1, Alyssa Ness1, Laurent Wall2, Caitlin McClurg1, Arshya Pooladi-Darvish3, Amanda Weightman2, Annalee Coakley1 1University of Calgary, Calgary, Canada; 2Habitus Consulting Collective, Calgary, Canada; 3University of Western Ontario, London, Canada BMC Proceedings 2026, 20(29):11 Background Refugees and migrants face inequities in healthcare and vaccination access. Diverse vaccination programs have been implemented globally to address refugee specific COVID-19 inequities to access, hesitancy and barriers to vaccination. The aim of this scoping review was to review evidence on the models of delivery of COVID-19 and other vaccinations for refugee and migrant populations. Methods A scoping review was conducted according to PRISMA guidelines. Eleven electronic databases including SCOPUS, Embase, Medline, and Web of Science as well as grey literature were searched with the keywords COVID-19, vaccines/immunizations, refugees, asylum seekers, and immigrants for all studies published between the years 2000 to October 2023. The main outcome was models of delivery of COVID-19 vaccines or other vaccines for refugee or migrant populations. Models of delivery were reviewed and thematically analyzed using the World Health Organization’s 2022 operational guide, Strengthening COVID-19 vaccine demand and uptake in refugees and migrants. Results A total of n=11,825 unique studies were identified through database searches. A total of thirty-three (n=33) studies met full-text inclusion criteria and were included in this review. Fifteen studies (n=15) focused on the COVID-19 vaccine, while other studies (n=18) focused on influenza (n=6), HPV (n=2), Hepatitis B (n=2), multiple vaccines (n=5), and polio, cholera, and meningococcal vaccinations (n=3). COVID-19 vaccine models of delivery often utilized innovative social media strategies and relied on frameworks to drive interventions. Furthermore, models of vaccine delivery included multiple components which leveraged community and multi-stakeholder partnerships and co-design strategies, while striving to deliver culturally-sensitive approaches with accessible vaccination services. Conclusions Models of vaccine delivery for refugees and migrants are multipronged, utilizing various strategies and extensive community and multisectoral collaborations to address accessibility barriers in alignment with most WHO recommendations for vaccinating refugee and migrant populations. An increasing reliance on innovative social media, co-design, and customization strategies drives interventions. Further collection and use of disaggregated real-time data to inform and evaluate customized strategies for specific migrant groups is recommended. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 Interventions & Evidence 12 School opening associated with significantly lower test-adjusted COVID-19 case rates in children Ambarish Chandra1, Tracy Høeg2 1University of Toronto, Toronto, Canada; 2Massachusetts Institute of Technology, Cambridge, USA BMC Proceedings 2026, 20(29):12 Editorial Comments: Accepted for oral abstract presentation. Pillar 2 Interventions & Evidence (data challenges/other) Currently published as a full manuscript and citation below:Chandra A, Høeg TB. School opening associated with lower test-adjusted COVID-19 case rates in children. Int J Epidemiol. 2025 Jun 11;54(4):dyaf113. https://doi.org/10.1093/ije/dyaf113. https://pubmed.ncbi.nlm.nih.gov/40587416/ Chandra A, Høeg TB. School opening associated with lower test-adjusted COVID-19 case rates in children. Int J Epidemiol. 2025 Jun 11;54(4):dyaf113. https://doi.org/10.1093/ije/dyaf113. https://pubmed.ncbi.nlm.nih.gov/40587416/ Chandra A, Høeg TB. School opening associated with lower test-adjusted COVID-19 case rates in children. Int J Epidemiol. 2025 Jun 11;54(4):dyaf113. https://doi.org/10.1093/ije/dyaf113. https://pubmed.ncbi.nlm.nih.gov/40587416/ 13 Controlling outbreak of infectious disease using Non-Pharmaceutical Interventions (NPIs): learning from Kerala’s response Nipah virus outbreak Rajnish Prasad IIHMR University, Jaipur, India BMC Proceedings 2026, 20(29):13 Objectives Emerging infectious diseases demand rapid, coordinated responses to minimize public health, social, and economic impacts. Nipah virus (NiV), a bat-borne zoonotic pathogen with a case fatality rate ranging from 40% to 100%, presents unique challenges due to its high fatality rate, lack of effective therapies, and potential for person-to-person transmission. Kerala, India, faced its fourth NiV outbreak in 2023 and successfully implemented a community-driven response centered on non-pharmaceutical interventions (NPIs) and adaptive strategies. This paper examines Kerala’s response, with a specific focus on its innovative use of NPIs, governance mechanisms, and community engagement. Methods Upon confirmation of the first Nipah case in 2023, Kerala activated a multi-pronged response within hours. A centralized control room and 24x7 call center were established to coordinate efforts. Key interventions included deploying 19 specialized teams comprising 190 members, supported by 200 volunteers and personnel from the police and forest departments. Innovative use of technology, such as mobile tower data for mapping patient travel routes, expedited contact tracing and isolation. Temporary triage centers and isolation units were set up, supported by a field laboratory for rapid diagnostics. Public engagement was integral, with daily press briefings, awareness campaigns on virus transmission, and advisories to neighboring states. Kerala’s decentralized governance allowed district-level task forces to act promptly, reducing the bureaucratic lag in implementing containment measures. Results The robust response successfully contained the outbreak within a week, limiting it to just six confirmed cases and two fatalities. The coordinated efforts minimized disruptions to public life and prevented wider transmission across the region. Conclusions Kerala’s experience with the 2023 Nipah outbreak highlights the critical importance of preparedness, decentralized governance, and community engagement in managing epidemics. The state’s success was driven by leveraging technology for rapid epidemiological mapping and resource allocation, enhancing health system infrastructure and readiness, and fostering trust through transparent and participatory communication. Kerala’s approach provides a replicable model for global public health systems, particularly in resource-constrained settings, emphasizing the need to integrate scientific advancements with community resilience to address the growing threat of emerging infectious diseases. Editorial Comments: Accepted for oral abstract presentation. Pillar 2- Interventions and Evidence (data challenges/other) 14 From ‘CoWIN’ to ‘Vaccine Maitri’ (vaccine friendship): India’s journey in combating COVID-19 pandemic Kamal Gulati All India Institute of Medical Sciences, New Delhi, India BMC Proceedings 2026, 20(29):14 Objectives The COVID-19 pandemic presented a significant challenge to global public health systems. In response, launched on 16 January 2021, India’s vaccination program—the largest in the world—emerged as a cornerstone of its strategy. This study provides a comprehensive analysis of India’s vaccination efforts, focusing on four critical areas: (i) the strengths and challenges of the CoWIN platform, (ii) the strategies and obstacles in achieving vaccination milestones for a diverse population, (iii) the initiatives to combat misinformation and myths surrounding vaccines, and (iv) India’s global role in vaccine diplomacy through the “Vaccine Maitri” initiative. These dimensions unravel the complexities and innovations involved in implementing the world’s largest vaccination programme in one of the most populous, democratic and diverse nations (1.4 billion people, 28 states, 8 union territories, 22 major languages, and almost all religions). Methods A comprehensive review of India’s vaccination program was conducted to assess its key components and outcomes. Data was collected from government reports, academic studies, and reputable media sources to analyze the design, implementation, and challenges of the CoWIN platform. The study further examined the strategies behind the vaccination rollout, including phased implementation, public-private partnerships, and community outreach efforts. Methods for addressing misinformation were evaluated by analyzing public awareness campaigns and the role of trusted community influencers. Finally, India’s vaccine diplomacy efforts were explored in the context of its international commitments under the COVAX program alongside its pressing domestic priorities. This multi-faceted approach aimed to derive actionable insights and lessons from the successes, failures, and unintended consequences of the world’s largest vaccination programme. Results The CoWIN platform served as a digital backbone for India’s vaccination drive, offering scalability and real-time data management. It streamlined vaccine registration, scheduling, tracking, and certification. As of January 2023, there were more than one billion registrations on the portal, with 5132 health facilities providing vaccinations slots. However, challenges arose in reaching rural and illiterate populations due to limited internet access and digital literacy. India’s phased rollout targeted frontline workers and vulnerable groups, expanding to younger age cohorts. Decentralized implementation allowed state governments to tailor strategies. Public-private partnerships, vaccination camps, and door-to-door campaigns extended reach, though logistical challenges and supply constraints persisted, particularly in underserved and remote regions. Vaccine-related myths and misinformation hindered acceptance. Government campaigns, media engagement, and trusted community influencers helped dispel myths. India’s “Vaccine Maitri” initiative demonstrated global leadership and diplomacy, supplying vaccines to more than 100 countries with over 250 million doses, despite pressing domestic demands. Conclusions India’s vaccination programme during the COVID-19 pandemic highlights the potential of leveraging digital platforms, innovative strategies, and global partnerships in managing public health crises. The CoWIN platform’s scalability and transparency highlighted the value of digital solutions, while the phased rollout and community engagement strategies demonstrated the importance of adaptability and inclusivity. Efforts to counter misinformation emphasized the need for proactive communication and trust-building, and the “Vaccine Maitri” initiative showcased India’s role as a global health leader. Key lessons include the need to bridge digital and infrastructural divides, balance domestic and global responsibilities, and foster resilience through equitable and efficient public health systems. These insights provide valuable guidance for future pandemic preparedness and response efforts. Editorial Comments: Accepted for oral presentation. Pillar 3 - Practice and Policy (methodological issues/other) 15 Return-to-work for people living with long COVID: a scoping review of interventions and recommendations Gagan Nagra1, Victor Ezeugwa1, Geoff Bostick1, Erin Branton1, Elizabeth Dennett1, Kevin Drake2, Quentin Durand-Moreau1, Christine Guptill3, Mark Hall1, Chester Ho1,4, Pam Hung1, Aiza Khan1, Grace Lam1, Behdin Nowrouzi-Kia5, Douglas Gross1 1University of Alberta, Edmonton, Canada; 2Workers’ Compensation Board of Alberta, Edmonton, Canada; 3University of Ottawa, Ottawa, Canada; 4Alberta Health Services, Edmonton, Canada; 5University of Toronto, Toronto, Canada BMC Proceedings 2026, 20(29):15 Introduction The COVID-19 pandemic has been described as a mass-disabling event and longer term consequences of the infection (i.e., Long COVID) continue to pose challenges for many working-age adults living with the condition. People living with Long COVID are often unable to perform regular work tasks and require prolonged work accommodations. Long COVID symptoms are often heterogeneous, fluctuating and unpredictable, which creates challenges for workers, their employers, as well as workers’ compensation boards and private disability insurers. Long COVID affects individuals’ labour market participation in many ways. While some cannot work at all, others may return to work (RTW) in a limited capacity. Determining what rehabilitation or related strategies are safe and effective for facilitating RTW is necessary. There is an urgent need for interventions that support return to meaningful life roles including work. Objectives To synthesize evidence on RTW interventions for people living with Long COVID and to identify ‘promising’ interventions for enhancing work ability and RTW. Methods We followed Arksey & O’Malley’s methodology and the PRISMA extension for scoping reviews. We conducted a comprehensive search of multiple databases (Embase, MEDLINE, CINAHL, BASE, CENTRAL, Cochrane, PsycINFO, OAIster, MedRxiv) and grey literature up to November 7, 2023, following Arksey & O’Malley’s scoping review framework. The included various study designs, such as randomized controlled trials, quasi-experimental designs, and observational studies. Two reviewers conducted screening and data extraction, with disagreements resolved through consensus. Intervention studies were categorized as promising (statistically significant RTW outcomes or ≥ 50% RTW), somewhat promising (20% to < 50% RTW), or not promising (non-statistically significant RTW outcomes or < 20% RTW). Results Eleven recommendations and eleven intervention studies were identified. Of the intervention studies, 6 were cohort studies, 3 quasi-experimental studies, 1 randomized controlled trial and 1 case report. Promising interventions included multimodal and interdisciplinary work-focused rehabilitation (1 article), psychoeducation, pacing, and breathing strategies (2 articles), shifting focus from symptom monitoring to optimizing functional outcomes (1 article), and enhanced external CounterPulsation (EECP) inflatable pressure to improve blood flow (1 article). Conclusions Many uncertainties remain regarding which RTW interventions are effective or the optimal characteristics of these interventions. Potential strategies were identified for optimizing work ability and supporting RTW in people living with Long COVID. Findings will inform future research directions on the development of RTW rehabilitation interventions. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence 16 Capacities and vulnerabilities of non-health essential workers from visible minority communities to cope with mental health effects during the COVID-19 pandemic Nashit Chowdhury1, Nafiza Rahman2, Christine Walsh1, Ranjan Datta3, Tanvir Turin Chowdhury1 1University of Calgary, Calgary, Canada; 2Community Scholar, Calgary, Canada; 3Mount Royal University, Calgary, Canada BMC Proceedings 2026, 20(29):16 Objectives The COVID-19 pandemic has disproportionately affected essential workers from visible minority communities. This study explores their capacities and vulnerabilities at the individual, household, community, and workplace levels to inform targeted interventions. Methods Fourteen non-health essential workers (e.g., grocery, transport, factory workers) from visible minority communities in Calgary, Canada, participated in semi-structured interviews. Thematic analysis was conducted using the capacities and vulnerabilities framework. Results Four main themes emerged: 1) Individual Capacities and Vulnerabilities, 2) Household Capacities and Vulnerabilities, 3) Community Capacities and Vulnerabilities, and 4) Workplace Capacities and Vulnerabilities. Individual capacities included resilience, adaptability, and proactive information-seeking, while vulnerabilities encompassed fear of infection, mental health challenges, and work-life balance struggles. At the household level, family support and cohesion were key capacities, while financial strain, job insecurity, and disruptions to family routines were significant vulnerabilities. Community capacities included strong social connections, cultural and religious support systems, and informal resource sharing networks. However, social isolation’s impact on mental well-being and limited access to culturally sensitive mental health resources were identified as community vulnerabilities. Workplace capacities included supportive employers, safety protocols, and peer support systems, while inadequate protection, high-risk work environments, and limited access to mental health support were notable vulnerabilities. Conclusions The capacities and vulnerabilities framework reveals the complex experiences of essential workers from visible minority communities in Calgary during the COVID-19 pandemic. Interventions should focus on enhancing capacities and addressing vulnerabilities at the individual, household, community, and workplace levels to support these workers’ resilience and well-being effectively. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence 17 Addressing youth mental health literacy for pandemic and public health crises: evidence-based consensus statements for the youth MindTrack and beyond Stephana Julia Moss1, Sonia Siddiqui1, Cristina Zuniga Chacon1, Cynthia Sriskandarajah1, Maia Stelfox2, Ben Gaunce1, Micaela Harley3, Stacie Smith4, Sofia Ahmed5, Kathryn Birnie6, Donna Halperin7, Scott Halperin1, Christine Hampson8, Jia Hu6, Laura Leppan1, Angie Nickel1, Kristine Russell1, Andrea Soo6, May Solis1, Henry Stelfox5, Sharon Straus2, Perri Tutelman6, Quincy Wiele8, Kristen Fiest6, Jeanna Parsons Leigh1 1Dalhousie University, Halifax, Canada; 2University of Toronto, Toronto, Canada; 3Royal’s Institute of Mental Health Research, Toronto, Canada; 4Young Canadian Roundtable on Health, Toronto, Canada; 5University of Alberta, Edmonton, Canada; 6University of Calgary, Calgary, Canada; 7St. Francis Xavier University, Antigonish, Canada; 8Sandbox Project, Toronto, Canada BMC Proceedings 2026, 20(29):17 Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence Currently published as a full manuscript and citation below:Moss, S.J., Siddiqui, S., Zuniga Chacon, C. et al. Evidence based consensus statements for digital tools to address youth mental health literacy. Sci Rep 15, 28208 (2025). https://doi.org/10.1038/s41598-025-12947-yhttps://www.nature.com/articles/s41598-025-12947-y Moss, S.J., Siddiqui, S., Zuniga Chacon, C. et al. Evidence based consensus statements for digital tools to address youth mental health literacy. Sci Rep 15, 28208 (2025). https://doi.org/10.1038/s41598-025-12947-yhttps://www.nature.com/articles/s41598-025-12947-y Moss, S.J., Siddiqui, S., Zuniga Chacon, C. et al. Evidence based consensus statements for digital tools to address youth mental health literacy. Sci Rep 15, 28208 (2025). https://doi.org/10.1038/s41598-025-12947-yhttps://www.nature.com/articles/s41598-025-12947-y 18 Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial Runar Solberg1, Atle Fretheim1,2, Ingeborg Hess Elgersma3, Mette Fagernes4, Bjørn Gunnar Iversen4, Lars Hemkens5,6,7, Christopher James Rose1,8, Petter Elstrøm1 1Centre for Epidemic Interventions Research (CEIR), Norwegian Institute of Public Health, Oslo, Norway; 2Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway; 3Centre for Epidemic Interventions Research (CEIR), Norwegian Institute of Public Health, Oslo, Norway; 4Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway; 5Pragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland; 6Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland; 7Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Standford, USA; 8Cluster for Reviews and Health Technology Assessments, Division for Health Services, Oslo, Norway BMC Proceedings 2026, 20(29):18 Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence (methodological issues/other) Currently published as a full manuscript and citation below: Solberg RB, Fretheim A, Elgersma IH, Fagernes M, Iversen BG, Hemkens LG, Rose CJ, Elstrøm P. Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial. BMJ. 2024 Jul 24;386:e078918. https://doi.org/10.1136/bmj-2023-078918. https://www.bmj.com/content/386/bmj-2023-078918 Solberg RB, Fretheim A, Elgersma IH, Fagernes M, Iversen BG, Hemkens LG, Rose CJ, Elstrøm P. Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial. BMJ. 2024 Jul 24;386:e078918. https://doi.org/10.1136/bmj-2023-078918. https://www.bmj.com/content/386/bmj-2023-078918 Solberg RB, Fretheim A, Elgersma IH, Fagernes M, Iversen BG, Hemkens LG, Rose CJ, Elstrøm P. Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial. BMJ. 2024 Jul 24;386:e078918. https://doi.org/10.1136/bmj-2023-078918. https://www.bmj.com/content/386/bmj-2023-078918 19 Understanding and communicating the potential benefits and harms of non-pharmacological interventions during health emergencies: a Nigerian perspective James Olufemi Famuyiwa Federal University of Technology, Akure, Nigeria BMC Proceedings 2026, 20(29):19 Effective communication of health benefits and risks of Non-Pharmacological Interventions (NPIs) is crucial in ensuring patient safety and informed decision-making, especially during health emergencies when information is inadequate. In Nigeria, several challenges hinder individuals making well-informed healthcare choices. Low literacy rates are a major barrier, with about 34.2% of adults unable to read or write. This is particularly pronounced in rural areas where healthcare services and educational opportunities are limited. Low literacy levels make it difficult for people to interpret medical information, evaluate treatment options, and follow healthcare recommendations, often resulting in poor health outcomes. Cultural beliefs, and traditional practices also strongly influence perceptions of modern medicine. Many Nigerians maintain deeply rooted cultural views on health and wellness, including a strong preference for traditional remedies to manage chronic conditions like hypertension and diabetes, as well as bone fractures. While valuable in some respects, these traditional approaches, frequently clash with modern medical practices, creating misunderstandings between patients and healthcare providers. These tensions can lead to reduced adherence to prescribed treatments, as patients hesitate to embrace medical recommendations that conflict with cultural norms. Additionally, with over 40% of Nigerians living below the poverty line, financial constraints prevent many from seeking professional healthcare, consequently, individuals often opt for self-medication or unregulated treatments as more affordable alternatives, for instance, 70% of Nigerians self-medicate, using over-the-counter medications including antibiotics and painkillers. Unfortunately, these alternatives often lead to harmful outcomes, such as drug dependency, ineffective management of chronic conditions, and an increased risk of side effects. NPIs provide an opportunity to bridge these gaps and increase acceptance of modern healthcare, as they could reduce the socioeconomic barriers that compound the challenges restricting healthcare access for a large percentage of the population. To address these multifaceted barriers, healthcare providers must employ culturally sensitive and contextually relevant communication strategies. Simplifying medical information, engaging respected community leaders, and using local languages in health education campaigns can make messages more accessible and meaningful. Policy reforms and investments in healthcare infrastructure, particularly in rural areas, are essential to improving access to quality care and health information. With these efforts, amongst others, Nigeria may then be able to reduce health literacy gaps, promote safer healthcare practices, and support healthier populations across its diverse communities. Editorial Comments: Accepted for oral (via on-line from Nigeria) and poster presentation. Pillar 3 - Practice and Policy (methodological issues/other) References Afolabi, M. O., et al. (2019). Immunization campaigns in Northern Nigeria: Visual aids and cultural sensitivity in health communication. Journal of Public Health Communication, 15(3), 112–123.National Bureau of Statistics. (2021). Nigeria’s Population Statistics. Abuja: NBSNational Population Commission. (2019). Demographic and Health Survey. Abuja: NPCOmoniyi, T. (2020). Community Health and Traditional Leadership: Bridging the Gap in Nigeria. African Health Journal, 24(2), 45–58.Osemene, K. P., & Lamikanra, A. (2012). A study of the prevalence of self-medication practice among University Students in Southwestern Nigeria. Tropical Journal of Pharmaceutical Research, 11(4), 683.World Bank. (2020). Nigeria: Poverty and Equity Brief. Washington, D.C.: World BankWorld Health Organization (WHO). (2019). Traditional Medicine in Africa. Geneva: WHO Afolabi, M. O., et al. (2019). Immunization campaigns in Northern Nigeria: Visual aids and cultural sensitivity in health communication. Journal of Public Health Communication, 15(3), 112–123. Afolabi, M. O., et al. (2019). Immunization campaigns in Northern Nigeria: Visual aids and cultural sensitivity in health communication. Journal of Public Health Communication, 15(3), 112–123. National Bureau of Statistics. (2021). Nigeria’s Population Statistics. Abuja: NBS National Bureau of Statistics. (2021). Nigeria’s Population Statistics. Abuja: NBS National Population Commission. (2019). Demographic and Health Survey. Abuja: NPC National Population Commission. (2019). Demographic and Health Survey. Abuja: NPC Omoniyi, T. (2020). Community Health and Traditional Leadership: Bridging the Gap in Nigeria. African Health Journal, 24(2), 45–58. Omoniyi, T. (2020). Community Health and Traditional Leadership: Bridging the Gap in Nigeria. African Health Journal, 24(2), 45–58. Osemene, K. P., & Lamikanra, A. (2012). A study of the prevalence of self-medication practice among University Students in Southwestern Nigeria. Tropical Journal of Pharmaceutical Research, 11(4), 683. Osemene, K. P., & Lamikanra, A. (2012). A study of the prevalence of self-medication practice among University Students in Southwestern Nigeria. Tropical Journal of Pharmaceutical Research, 11(4), 683. World Bank. (2020). Nigeria: Poverty and Equity Brief. Washington, D.C.: World Bank World Bank. (2020). Nigeria: Poverty and Equity Brief. Washington, D.C.: World Bank World Health Organization (WHO). (2019). Traditional Medicine in Africa. Geneva: WHO World Health Organization (WHO). (2019). Traditional Medicine in Africa. Geneva: WHO 20 Evaluating public values on non-pharmaceutical interventions for pandemic control Yuan Zhang1,2, Kyle Lloyd2, Shahab Sayfi1, Jessica Bartoszko1, Adam Komorowski1, Mark Loeb1 1McMaster University, Hamilton, Canada; 2Brock University, St Catharines, Canada BMC Proceedings 2026, 20(29):20 Objectives This study aims to evaluate public values and preferences regarding the benefits and harms of non-pharmaceutical interventions (NPIs) for pandemic control. Understanding these values is crucial for informed public health decision-making during health emergencies. Methods A comprehensive literature search will be conducted using Medline, Embase, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature from inception to the current date. The search strategy incorporates three main concepts: pandemics, NPIs, and values/preferences. Grey literature sources and reference lists of included studies will be manually searched for additional relevant studies. Studies will be screened independently by two authors, with disagreements resolved through discussion or third-party adjudication. Data extraction will focus on study characteristics, methods, and results related to public value elicitation. The ROBVALU tool will be used to assess the risk of bias in the studies included. Results This review is currently in progress. We anticipate identifying a diverse range of studies assessing public values and preferences towards NPIs. The included studies are expected to vary significantly in design, measurement methods, and outcomes. We plan to tabulate and categorize the results by the perceived benefits and harms of specific NPIs, such as physical distancing and school closures. One of the primary challenges of this project is the difficulty in defining the benefits and harms of NPIs. NPIs, such as physical distancing, school closures, and travel restrictions, have multifaceted impacts that vary across different populations and contexts. The outcomes, such as reduced transmission rates and decreased healthcare burden, are often easier to define. However, outcomes especially harm, which can include mental health issues, economic losses, and educational disruptions, are more complex and subjective. Conclusions The findings from this review will provide valuable insights into the complexity and variability of public opinions on NPIs for pandemic control. These insights will be crucial for incorporating public values into public health decision-making, ultimately enhancing the effectiveness and acceptance of NPIs. Public values and preferences regarding these interventions can be highly diverse and influenced by cultural, social, and individual factors. The values and preferences may be dynamic and have changed during the pandemic. These heterogeneities and dynamics make it challenging to develop a standardized approach for integrating these values into public health decision-making. Future research should focus on developing standardized methods for eliciting and integrating public values into health policy frameworks. Editorial Comments: Accepted as oral presentation. Pillar 2 - Interventions and Evidence (data challenges) 21 Post-COVID-19 condition impact on the Canadian healthcare workforce: a living systematic review and agent-based modelling project Madison McGuire1, Julian Little1, Nicole Shaver1, Lama Dahroug1, Taddele Kibret1, Erin Collins1, Ahmed Al-Jaishi2,3, Rojiemiahd Edjoc2, Nicholas Dehler1, Lea Lamp2, Muhammed Salah Khan2, Sarah Hughes4, Anne Marie Rafferty5, Ellen Rafferty6, Seana Semchishen1, Gary Groot7, Wendy Laframboise8, Carol Mann9 1University of Ottawa, Ottawa, Canada; 2Public Health Agency of Canada, Ottawa, Canada; 3Western University, London, Canada; 4University of Birmingham, Birmingham, UK; 5King’s College London, London, UK; 6Institute of Health Economics, Alberta, Canada; 7University of Saskatchewan, Saskatchewan, Canada; 8The Ottawa Hospital Rehabilitation Centre, Ottawa, Canada; 9Ottawa Hospital Research Institute, Ottawa, Canada BMC Proceedings 2026, 20(29):21 Objectives One consequence of COVID-19 is the persistence of symptoms, known as post-COVID-19 condition (PCC). A substantial proportion of individuals with PCC miss work, including those in the healthcare sector, where workers are more likely to be exposed to COVID-19 than the general population. Internationally, there is concern about effects on healthcare workers and the healthcare system, including worker burnout, absenteeism, and leaving the profession. Potentially, these could lead to reduced productivity, long-term economic consequences, and healthcare system strains. The evidence on PCC prevalence and how it impacts the workforce have not been integrated. Therefore, this research aims to quantify the prevalence of PCC and its impacts on the healthcare workforce using existing literature and estimate the projected impacts of PCC on the healthcare workforce using agent-based modelling. Methods A living systematic review was conducted to investigate PCC prevalence in the working-age population and the effects of PCC on work-related outcomes including occupational effects (e.g., stress, burnout) and workforce effects (e.g., absenteeism, productivity loses, staff shortages). Barriers and facilitators for return-to-work (RTW) were also extracted. We searched electronic databases and grey literature from May 2023 to May 2024. Screening was performed by two reviewers, while data extraction and risk of bias assessment were completed by one reviewer with verification by a second reviewer. We then created an agent-based model that estimates 1-year projections of the impacts of PCC on Canada’s healthcare workforce. The parameters used to populate the model were informed by the evidence review. Results Results were highly heterogeneous between studies. Although PCC prevalence ranged widely between studies (0.9% to 96.2%), overall PCC prevalence decreased with time after infection. While most individuals RTW within six months to a year (median: 93.4%, range: 63%−98.5%), multiple studies report impaired productivity and delayed RTW, particularly among those with severe or persistent symptoms. RTW barriers were related to the impact of physical and cognitive symptoms on meeting job demands, and facilitators included fostering supportive relationships, offering flexible work patterns, adjusting workloads and tasks, providing leave and benefits, and ensuring access to healthcare, PPE, and mobility aids. Modelling estimated that 66% of healthcare workers with PCC would RTW without modifications within one year after infection compared to 85% of those without PCC. Workers with PCC were twice as likely to have lower work productivity, miss shifts, or require a leave of absence compared to those without PCC one year post-infection. Conclusions Results from our review and model highlight the impact of PCC on individual healthcare workers and the cumulative impact PCC has on the healthcare system. There are no standardized outcome definitions and reporting guidelines for workforce-related research among people living with PCC. As a result, data from existing literature are highly heterogeneous because of differing designs and varying outcome definitions, compounded by sub-optimal reporting. High-quality research data are needed to ensure policies are based on high-quality evidence. Our results highlight the value of workplace accommodations for those experiencing PCC symptoms. Given the high prevalence of individuals unable to work or experiencing productivity losses, enhanced health disability benefits may allow affected individuals to focus on their recovery and eventual return to the workplace. Editorial Comments: Accepted for oral abstract presentation. Pillar 3 - Practice and Policy 22 Gaps in using immunological markers to study interventions: insights from the COVID-19 pandemic Nicole Shaver1, Lama Dahroug1, Melanie Katz1, Gideon Darko Asamoah1, Madison McGuire1, Lori-Ann Linkins2, Wael Abdelkader2, Alexandria Bennett1, Angela Barbara2, Sarah E. Hughes3, Maureen Smith4, Mpho Begin5, Doug Coyle1, Thomas Piggott2, Benjamin Kagina6, Vivian Welch7, Caroline Colijn8, David Earn2, Khaled El Emam1, Jane Heffernan9, Sheila O’Brien1, Kumanan Wilson1, Erin Collins1, Tamara Navarro2, Joseph Beyene2, Isabelle Boutron10, Dawn Bowdish2, Curtis Cooper1, Andrew Costa2, Janet Curran11, Lauren Griffith2, Amy Hsu1, Jeremy Grimshaw12, Marc-André Langlois1, Xiaoguang Li13, Anne Pham-Huy1, Parminder Raina2, Michele Rubini14, Lehana Thabane2, Hui Wang13, Lan Xu13, Melissa Brouwers1, Tanya Horsley15, John Lavis2, Alfonso Iorio2, Julian Little1 1University of Ottawa, Ottawa, Canada; 2McMaster University, Hamilton, Canada; 3University of Birmingham, Birmingham, UK; 4The Cochrane Consumer Network, Ottawa, Canada; 5Cassidy e-Care Solutions Inc, Winnipeg, Canada; 6University of Cape Town, Cape Town, South Africa; 7Bruyère Research Institute, Ottawa, Canada; 8Simon Fraser University, Burnaby, Canada; 9York University, Toronto, Canada; 10Université Paris Cité, Paris, Canada; 11Dalhousie University, Halifax, Canada; 12Ottawa Hospital Research Institute, Ottawa, Canada; 13Shanghai Jiao Tong University, Shanghai, China; 14University of Ferrara, Ferrara, Italy; 15Royal College of Physicians and Surgeons of Canada, Ottawa, Canada BMC Proceedings 2026, 20(29):22 Objectives Evidence from studies of immunological markers to interventions has the potential to help address evidence gaps as pandemics emerge and evolve. These studies are often used to inform timely public health decision-making before the completion of large-scale observational studies of clinical outcomes. We conducted a living systematic review of COVID-19 vaccine effectiveness (VE) against variants of concern on immunological responses in adults. Lessons learned from completing this evidence synthesis during the COVID-19 pandemic are drawn and we highlight gaps in the current state of immunological research and evidence synthesis. Methods A Living Evidence Synthesis was conducted between January 2020 and April 2023 to examine COVID-19 VE against variants of concern for immunological outcomes, including neutralization antibody activity, anti-SARS antibody titers, and cell-mediated immune response. We completed several iterations of the living review, with electronic databases systematically searched and screened in duplicate. Risk of bias assessments (RoB) for observational studies were performed using the Ottawa Newcastle Scale and the CONSISE ROSES-I reporting guideline and the Cochrane ROB-2 tool for randomized controlled trials. Results were synthesized narratively due to substantial heterogeneity. The conduct of our living evidence synthesis identified several areas for improvement in the conduct of primary immunological vaccine research and systematic review guidance for VE studies. Results We included a total of 212 studies out of 8360 records. Despite the large number of studies, substantial heterogeneity created problems in synthesizing results. Studies varied widely in their choice and the reporting of immunological outcomes, antibodies, assays, and laboratory standards, including the units of measurement, dilution percentages, measures of central tendency (e.g., GMT, median, and mean), and cut-off points used to evaluate immune responses. This heterogeneity highlights a critical lack of standardization and reporting across laboratories, especially in the early pandemic stages. Reporting of laboratory methods was particularly poor, with 94% of studies failing to report all items in the CONSISE ROSES-I reporting guideline section. Finally, we found a lack of validated tools for quality assessment. While existing quality assessment tools and reporting guidelines were modified to address key RoB concepts in immunological VE studies, there is a need for validated tools to ensure transparent and reproducible evidence syntheses. Conclusions Conducting a living systematic review of COVID-19 VE during the COVID-19 pandemic highlighted gaps in the current state of immunological research, including a substantial lack of standardization and appropriate reporting of methods across laboratories conducting primary immunological research. Additionally, we identified a lack of validated quality assessment tools to evaluate RoB in observational VE studies in general, as well as for immunological outcomes in particular. It is critical to address these gaps before the next pandemic or global public health crisis to support high-quality evidence synthesis and decision-making for both pharmaceutical interventions and non-pharmaceutical interventions. Editorial Comments: Accepted for poster presentation. Pillar 2 - Interventions and Evidence 23 Are masks necessary? A challenge to prevent COVID transmission on a pediatric mental health acute care unit Jennifer Happe, Joseph Vayalumkal, Jessica Dunn, Nadia Nazarali Alberta Children’s Hospital, Calgary, Canada BMC Proceedings 2026, 20(29):23 Objectives Masks are effective at reducing the risk of COVID transmission. Alberta Health Services (AHS) implemented a continuous masking policy during the pandemic to reduce COVID transmission, including encouraging inpatients to mask when they left their rooms. Staff reported incidents of pediatric mental health inpatients using the mask ear loops and the metal nose bridge for self-harm. This necessitated removal of masks from patient-accessible areas and reinforcement of other strategies to minimize the risk of COVID transmission. We assessed the impact of removing inpatient access to masks on COVID transmission. Methods Masks were removed from all patient-accessible areas of the mental health unit in 2022. Masks remained available in secure locations for staff to comply with the AHS continuous masking policy. Staff monitored patients twice daily for the development of COVID symptoms. Staff encouraged hand washing before patients left their room and before and after activities and meals. Group activities were limited to six participants to facilitate physical distancing. Symptomatic patients were excluded from group therapy, group recreation activities and eating in the common dining room. Incidence rates of hospital acquired COVID, and numbers of outbreaks were calculated between 2020 and 2023 and compared with a combination of six other hospital inpatient units (mixed medical/surgical and critical care units). Results Rates of hospital acquired COVID increased among patients on the mental health unit after patient mask use stopped in 2022: 0 cases per 10,000 patient days between 2020-2021 and 12.9 cases per 10,000 patient days in 2022-2023. The rate of hospital acquired COVID on the mental health unit was higher compared to six other combined inpatient units between 2022-2023 which was 1.3 cases per 10,000 patient days. Additionally, there were two COVID outbreaks on the mental health unit (in 2022 and 2023) compared to one COVID outbreak across the six other inpatient units combined (in 2022). All hospital acquired COVID cases remained on the mental health unit or were discharged home without the need for COVID-specific treatment on a medical acute care or critical care unit. Conclusions Eliminating patient masking was associated with an increase in COVID transmission events and outbreaks on the mental health unit. This outcome was thought to be acceptable given the mild, self-limited nature of COVID infections in this physically health patient population, relative to those on the other six inpatient units, compared to the possibility of self-harm from masks. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence (methodological issues) 24 Applying the COM-B model to assess barriers and facilitators of the Covid-19 pandemic public health measures in Black communities in Canada: a qualitative study Obidi Ezezika, Zantae Pellitier Western University, London, Canada BMC Proceedings 2026, 20(29):24 Objectives This study aimed to identify barriers and facilitators to adherence to public health measures (PHMs) among Black Canadians during the COVID-19 pandemic, with a focus on non-pharmacological interventions (NPIs) such as handwashing, mask wearing, social distancing, and sanitizing. Black communities in Canada, in particular, have faced unique barriers to adhering to these measures, exacerbated by socioeconomic challenges, cultural dynamics, and systemic health inequities. By leveraging the Capability, Opportunity, Motivation, and Behaviour (COM-B) model, the study sought to explore the factors influencing compliance and provide insights into how tailored strategies can be developed to improve adherence. The ultimate goal was to generate high-quality evidence that can inform the development and implementation of effective NPIs during future public health emergencies, ensuring that policies are responsive to the unique needs of diverse communities. Methods A qualitative descriptive approach was employed, utilizing semi-structured interviews and virtual focus groups to gather in-depth perspectives from 130 Black Canadians across four provinces (Ontario, British Columbia, Alberta, and Quebec). Participants were recruited through the database of the Federation of Black Canadians (FBC), using convenience and snowball sampling. We conducted semi-structured interviews with 130 individuals and four focus groups between November 2021 and June 2022. The semi-structured interviews and focus group discussions were conducted virtually over Zoom and lasted about 45 min each. The interviews were transcribed and coded professionally using team-based methods. Themes were developed using an inductive-deductive approach, defined through consensus, and guided by the COM-B model. This process allowed for a nuanced understanding of the sociocultural, environmental, and psychological factors that influence the effectiveness of NPIs in Black communities during the pandemic. Results The study identified several factors influencing adherence to public health measures (PHMs) in Black communities. Key barriers included limited access to handwashing facilities, discomfort with masks, space constraints for social distancing, and lack of sanitizers. Social and cultural norms, such as strong family bonds, conflicted with physical distancing. Psychological barriers like anxiety and mistrust in government measures also played a role. Facilitators included improved access to public health resources, clear communication, and community support. Effective health communication, culturally tailored messaging, and access to quality protective equipment were crucial enablers. Using the COM-B model, barriers aligned with five subcomponents: physical opportunity, physical capability, social opportunity, psychological capability, and automatic motivation, while facilitators aligned with physical opportunity, psychological capability, and automatic motivation. Physical opportunity was the most frequently mentioned factor, with 59% of barriers and 91% of facilitators aligning with this subcomponent. Conclusions The study underscores the need for targeted strategies to enhance adherence to NPIs in diverse communities, particularly among Black Canadians, during public health emergencies. To ensure the effectiveness of NPIs, it is essential to identify and address barriers such as social stigma, cultural norms, and environmental limitations. This study observed that the limited capacity to engage in social distancing and lack of access to handwashing stations, supplies, and sanitizing products, along with external factors, such as government policies on mask wearing and availability of resources, significantly influenced adherence to public health measures. The comprehensive exploration of these results highlighted the intricate dynamics informing handwashing, mask wearing, sanitization, and social distancing during the COVID-19 pandemic. This study emphasizes the importance of creating inclusive and evidence-based strategies to in relation to NPIs on vulnerable populations. Editorial Comments: Accepted for oral abstract presentation. Pillar 2- Interventions and Evidence (data challenges/other) 25 Reporting quality of diagnostic accuracy studies for viral infections of enhanced pandemic potential: protocol for a meta-epidemiologic systematic review and meta-regression Adam S. Komorowski1,2,3,4,5, Vithushan Surendran6, Manahil Qureshi7, Jessica J. Bartoszko1,4, Mariska M.G. Leeflang8, Mark Loeb1,2,3,4,5,9 1Pandemic EVIDENCE Collaboration, Kellogg College, University of Oxford, Oxford, UK; 2Microbiology Department, Hamilton Regional Laboratory Medicine Program, Hamilton, Canada; 3Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada; 4Department of Health Research Methodology, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada; 5Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Canada; 6Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Canada; 7McMaster University, Hamilton, Canada; 8Department of Epidemiology and Data Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands; 9Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Canada BMC Proceedings 2026, 20(29):25 Background It is unclear whether the quality of diagnostic test accuracy studies has markedly improved since the STARD guideline was published in 2015. The primary objective of this systematic review is the evaluation of the reporting quality of studies evaluating the diagnostic accuracy of a test to diagnose viral infections of enhanced pandemic potential in humans. We will also assess reporting quality by funding source and publication year. Methods We searched Medline, Embase, and Web of Science from inception to 22 September 2024. We will include prospective and retrospective 1- and 2-group studies that perform a diagnostic test on a specimen from a human patient, either alone or in combination with other tests, to diagnose the condition of interest in patients, and compare this test against a reference standard. To be included, studies must be performed in adult and/or pediatric patients with compatible clinical signs and/or symptoms, suspicion of infection with, or contact with a known case of a modified list of World Health Organization Research and Development Blueprint public health emergency priority pathogens that includes SARS-CoV-2 and highly pathogenic avian influenza viruses. Included studies will be compared to the STARD 2015 guideline reporting items. Screening and data extraction will be performed blinded and in duplicate using Covidence. QUADAS-2 and QUADAS-C tools will be used to assess risk of bias, which will be summarized descriptively within and across studies. Descriptive statistics were used to summarize data; statistical tests will be 2-sided, with significance defined as P <.05. Preplanned subgroup analyses include patient immune status, and trials including adults versus those that also include pediatric patients. A preplanned sensitivity analysis will be performed to remove studies at high risk of bias per QUADAS-2 or QUADAS-C assessment. We will compute a numerical score for each included paper based on the 30-point STARD checklist, and a random-effects meta-regression will be performed to compare the log-odds ratio of the calculated STARD score with study-level covariates such as publication year, publication region, and publication impact factor. The systematic review was prospectively registered on Open Science Framework; there have been no protocol amendments. Non-operational travel funding related to this work is provided by the MacCall MacBain Foundation, which had no role in the development of the research protocol. Editorial Comments: Accepted for poster presentation (protocol only). Pillar 1- Diagnostics and Transmission 26 Epidemiology and transmission of respiratory viruses among children attending day care: a systematic review Elizabeth Thomas1,2,3, Sajeev Jacob4, Adam Komorowski1,5,6,7,8, Sophie Wen2,3,9, Nia Roberts10, Mark Jones11, Susanna Maltoni12, Igho Onakpoya13, Sara Gandini14, Tom Jefferson13, John Conly15, Annette Plüddemann16, Carl Heneghan16 1Pandemic EVIDENCE Collaboration, Kellogg College, University of Oxford, Oxford, UK; 2Queensland Children’s Hospital, Brisbane, Australia; 3Child Health Research Centre, University of Queensland, Brisbane, Australia; 4Gold Coast University Hospital, Gold Coast, Australia; 5Microbiology Department, Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada; 6Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; 7Department of Health Research Methodology, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; 8Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada; 9Centre for Clinical Research, The University of Queensland, Brisbane, Australia; 10Bodleian Health Care Libraries, University of Oxford, Oxford, UK; 11Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia; 12Division of Research and Innovation, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy; 13Department of Continuing Education, University of Oxford, Oxford, UK; 14Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy; 15Departments of Medicine, Microbiology, Immunology & Infectious Diseases, and Pathology & Laboratory Medicine, Synder Institute for Chronic Diseases and O’Brien Institute for Public Health, Cumming School of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada; 16Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Oxford, UK BMC Proceedings 2026, 20(29):26 Background During the SARS-CoV-2 pandemic, children were the focus of numerous public health policies, including mask mandates and day care or school closures, despite limited supporting evidence. Community childcare centres are an important setting to study the epidemiology of respiratory viruses due to high rates of childhood infections, potential infection-related complications, and associated high rates of antibiotic use. Additionally, day care policies carry significant social implications including parental work absenteeism as well as the associated financial costs. This systematic review aims to assess the incidence, prevalence, and transmission of respiratory viruses among children attending day care centres. Methods We systematically searched Medline, Embase, CENTRAL, Global Health, Science Citation Index from inception to November 2024. Eligible studies included children aged ≤ 5 years attending community day care centres who underwent testing for respiratory viruses. Observational studies or control arms of randomized controlled trials were included. The primary outcomes of interest are: 1) incidence and prevalence of respiratory viruses in day care centres, and 2) transmission dynamics, including assessment methods (e.g., contact tracing, symptom timing, genetic sequencing). We also aim to report the following secondary outcomes: presence of symptoms, detection of multiple pathogens, duration of positive results, relationship between viral load and transmission, symptom severity, duration of positivity, virus-related complications, and risk factors that led to increased harms from viruses. The quality of included studies will be assessed against the JBI Critical Appraisal checklist for incidence and prevalence studies, and a modified QUADAS-2 tool for transmission studies. Editorial Comments: Accepted for poster presentation (protocol only). Pillar 1- Diagnostics and Transmission 27 Development of a risk of bias tool for quality assessment of studies of the transmission of respiratory viruses Adam S. Komorowski1,2,3,4,5, Elizabeth Thomas1,6,7, Annette Plüddemann1,8 1Pandemic EVIDENCE Collaboration, Kellogg College, University of Oxford, Oxford, UK; 2Microbiology Department, Hamilton Regional Laboratory Medicine Program, Hamilton, Canada; 3Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada; 4Department of Health Research Methodology, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada; 5Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Canada; 6Child Health Research Centre, The University of Queensland, South Brisbane, Australia; 7Queensland Children’s Hospital, South Brisbane, Australia; 8Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK BMC Proceedings 2026, 20(29):27 Objectives Studies of the modes of transmission of respiratory viruses are essential to provide evidence to inform public health and other measures to reduce respiratory virus transmission during seasonal outbreaks and pandemics. When assessing the study quality of included studies in a systematic review, a tool specifically designed to evaluate the risk of bias in studies assessing the transmission of respiratory viruses is lacking. Robust indicators of replicating and/or infectious viruses are required to estimate the proportion of virus shedding in quantifiable terms and verify the circumstances and relationship between exposure and outcome (chain of transmission). Lack of quality assessment or the use of heterogeneous tools may fail to identify reliable studies and introduce bias and distort conclusions. This study aims to systematically develop and evaluate a tool to assess the risk of bias in studies of the transmission of respiratory viruses, building on the tool we previously developed. Methods We will conduct a scoping review of tools used to assess the risk of bias in systematic reviews of respiratory virus transmission. We will combine findings from the scoping review with empirical evidence from multiple reviews on the transmission of respiratory viruses, expert opinion, and a formal consensus Delphi method. The list of possible items to include in the tool will be derived from previously conducted systematic reviews on respiratory virus transmission. Editorial Comments: Accepted for poster presentation (protocol only). Pillar 1- Diagnostics and Transmission 28 Prioritising Public Health and Social Measures (PHSM) evidence syntheses for a national public health agency Serena Carville, Angelique Mavrodaris UK Health Security Agency, London, UK BMC Proceedings 2026, 20(29):28 Objectives Public Health and Social Measures (PHSM) are non-pharmaceutical interventions that protect the health and well-being of communities by reducing transmission of an infection. During and following the COVID-19 pandemic, a considerable amount of research was undertaken to determine the effectiveness of PHSMs used for COVID-19. However, there remain unanswered research questions to inform use of PHSM in a future respiratory infection pandemic, or an infection that spreads through another route of transmission. Systematic or rapid evidence reviews are an important step in assessing and understanding the evidence base to make recommendations and guidance for public health advice on this topic. The research questions could be numerous and require substantial resource to conduct. A clear and transparent process is therefore required to identify the evidence gaps, define relevant research questions, and to prioritise those for evidence synthesis to inform advice, guidance and policy as part of pandemic preparedness and response. Methods A recent systematic review by Fadlallah et al. of proposed approaches or processes used to prioritise topics or questions for systematic reviews and other types of evidence syntheses was used as a basis. From the 29 papers identified, the authors developed a 25 criteria framework across 10 domains. Following the draft UK Health Security Agency (UKHSA) research prioritisation framework, this work sets out an adapted version of Fadlallah et al.’s recommendations to define a process that captures relevant public health considerations in pandemic preparedness and addresses the needs of the UKHSA PHSM evidence work programme. The prioritisation process does not address generation of the questions to consider. This will be done following steps in the draft UKHSA research prioritisation framework; considering any research priorities already defined in this area, and with stakeholder input. Results The UKHSA PHSM process proposes that review questions are considered against 5 domains: Availability of existing systematic reviews Availability of primary studies Implementation, ethical and moral considerations Interest in the topicExpected impact of applying the evidence. Availability of existing systematic reviews Availability of existing systematic reviews Availability of primary studies Availability of primary studies Implementation, ethical and moral considerations Implementation, ethical and moral considerations Interest in the topic Interest in the topic Expected impact of applying the evidence. Expected impact of applying the evidence. “Problem-related considerations” was removed as it was considered implicit in the work programme. This covered whether the topic related to a health or economic burden, burden on the healthcare system or an equity consideration, however the PHSM workstream has already been prioritised as an area relevant to all four of these criteria. Implementation considerations was merged with ethical and moral considerations, considering how the evidence review findings will be used and the issue they address. If a topic meets all other criteria, but is not amenable to a systematic review, it will be taken to the steering group for a decision of how best to address the need within the agency. Conclusions A 5-step prioritisation process has been developed to inform the prioritisation of PHSM evidence syntheses that will subsequently inform advice, guidance and policy on choice of PHSM, across infections that spread through any route of transmission. This has been used in the initial prioritisation to define 4 priority evidence synthesis topics. All prioritised topics will be considered by their urgency, to determine the order and timeframe in which they should be addressed. Capacity considerations will determine method of delivery, including collaboration with external partners as required. The prioritisation will be reviewed regularly, to consider new review questions or whether any of the criteria have changed. The process will be evaluated at the end of the work programme by considering; • What the evidence reviews went on to inform • What changed as a result of the evidence reviews • Were evidence gaps identified, and if so, are they informing any future research? Editorial Comments: Accepted for oral abstract presentation (protocol only). Pillar 2- Diagnostics and Evidence (methodological issues) 29 Translating evidence into policy and practice: an evidence informed public health and social measures work programme Serena Carville, Joshua Khan, Angelique Mavrodaris, Helen McAuslane UK Health Security Agency, London, UK BMC Proceedings 2026, 20(29):29 Seminar Background Public health and social measures (PHSM) are often the first (sometimes only) interventions available at the onset of a pandemic while clinical countermeasures are being developed and deployed. As a national public health body, the UK Health Security Agency (UKHSA) has a key role in advising on the implementation of PHSM. This was realised in the COVID-19 pandemic where a significant amount of work was undertaken by UKHSA and its predecessor Public Health England (PHE). Many learning points have been taken from COVID-19, including the challenges of providing advice in the absence of evidence or when faced with poor quality evidence. Harnessing this learning and knowledge from research generated is vital for ongoing pandemic preparedness. Objectives In 2024 UKHSA established a 3 - 5 year PHSM work programme. This programme builds on extensive work already undertaken in the UK and internationally and will extend beyond respiratory transmission to consider PHSM for other routes of transmission. The evidence on the effectiveness and negative impacts of PHSM is incomplete, most of the recent published evidence is in relation to COVID 19, and in many cases the evidence is of low to moderate quality. A holistic approach is therefore required which considers evidence generation, evidence synthesis, and the translation of that evidence into advice and guidance for policy makers, professionals and the public. The programme includes 3 workstreams; i) Evidence review and synthesis, ii) Research prioritisation and collaboration and ii) Translating evidence into advice and guidance. The programme objectives include, but are not limited to: review and synthesis of primary evidence and identification of evidence gaps.identification of research gaps and establishment of responsive research priorities, plans and collaborationsdevelopment of frameworks to support the production of guidance in a pandemicdevelopment of advice on implementation of PHSM to inform policy and decision makingdevelopment of a monitoring and evaluation framework for PHSM guidance and implementation. review and synthesis of primary evidence and identification of evidence gaps. review and synthesis of primary evidence and identification of evidence gaps. identification of research gaps and establishment of responsive research priorities, plans and collaborations identification of research gaps and establishment of responsive research priorities, plans and collaborations development of frameworks to support the production of guidance in a pandemic development of frameworks to support the production of guidance in a pandemic development of advice on implementation of PHSM to inform policy and decision making development of advice on implementation of PHSM to inform policy and decision making development of a monitoring and evaluation framework for PHSM guidance and implementation. development of a monitoring and evaluation framework for PHSM guidance and implementation. Forward look Work to date has focussed on mapping existing evidence syntheses for PSHM in respiratory infections, mapping primary research activity, prioritising the first stage of new evidence synthesis and collating research priorities, establishing internal and international research partnerships and networks, and developing a conceptual framework for the programme. Next steps include working with partners across sectors to triangulate and translate evidence into advice and guidance to inform policy, further develop research priorities including both evidence synthesis and primary research, develop research ‘sleeper’ protocols that could be initiated rapidly and help inform better evidence generation in future pandemics. This programme will continuously evolve and may require re-evaluation of the evidence and advice and guidance products as research, or the public health landscape change. Discussion points for our seminar include:What are the challenges of translating evidence into advice and guidance, including in the absence of evidence?What does best practice look like in the context of these challenges and absence of evidence?What are the known evidence gaps and research priorities?How can international collaboration be harnessed to help address these challenges? What are the challenges of translating evidence into advice and guidance, including in the absence of evidence? What are the challenges of translating evidence into advice and guidance, including in the absence of evidence? What does best practice look like in the context of these challenges and absence of evidence? What does best practice look like in the context of these challenges and absence of evidence? What are the known evidence gaps and research priorities? What are the known evidence gaps and research priorities? How can international collaboration be harnessed to help address these challenges? How can international collaboration be harnessed to help address these challenges? Editorial Comments: Accepted for oral presentation. (Seminar). Pillar 3 - Practice and Policy 30 Exploring the importance of perspective in study design to assess the effects or impacts of non-pharmacological interventions during public health emergencies Tara Schuller Institute of Health Economics, Edmonton, Canada BMC Proceedings 2026, 20(29):30 Seminar Objectives The evaluation of non-pharmaceutical interventions (NPIs) requires an appropriate study design to produce valid and robust results within the resource constraints ubiquitous in research. Those seeking to study the impacts of NPIs must determine which successes, failures, and unintended consequences will be assessed. Such decisions inform the study scope and reveal which impacts, and whose experiences or perspectives, count. For this reason, it is good practice to define in advance the study perspective (from which point of view the investigation is conducted). The perspective frames or scopes the study, and informs the selection of the effects to be measured. For the assessment of NPIs with broad impact in particular, such as those implemented during the COVID-19 pandemic, embedding contextual factors into impact studies can optimize results for local decision making, but it can make results difficult to compile, compare, and translate to other jurisdictions around the globe. Methods Selecting the appropriate perspective is important to generate high-quality evidence for non-pharmacological interventions during public health emergencies. Drawing on examples from the domain of health technology assessment, this seminar will engage participants in the consideration of two common perspectives taken in the evaluation of healthcare interventions: the healthcare payer perspective and the societal perspective. In the healthcare payer perspective, only those costs and benefits that affect the healthcare system are included, for example patient health outcomes, wait times, access to care, or clinician satisfaction. Costs or benefits that accrue outside the health system, such as to worker absenteeism, educational delays in children, or social isolation of seniors (etc.) are not assessed. These kinds of broader impacts would instead be captured in the societal perspective, along with potentially many other kinds of costs and benefits spanning socioeconomic, psychosocial, and environmental factors that affect different stakeholders in different settings. Results Through the short presentation of definitions, theoretical background, and practical examples, the audience will be engaged in facilitated discussion to ways to improve the quality of research on NPIs and the transferability of findings for global knowledge sharing. The results will be to co-create knowledge among participants about the importance of study perspective in assessing the impacts of NPIs implemented during public health emergencies. Subthemes such as weighting as well as the consideration of short- and long-term consequences will be explored. Possible solutions will be postulated to address challenges raised. For example, to improve the comparability of results of NPIs research, it may be useful to differentiate the technical evaluation of NPIs from the appraisal or decision-making step which follows (at which point weighting or other factors could be brought to bear on the evidence in a deliberative process). Conclusions As the domain of NPI evaluation advances to generate a corpus of high-quality evidence and to support efficient knowledge exchange globally, the implications of different perspectives and weightings of results may need to be considered. Different study design elements like perspective and weightings present opportunities to tailor evidence to more appropriately inform local decision making, but they can also introduce barriers to the comparative potential of results and their transferability to jurisdictions across the globe. Editorial Comments: Accepted for oral presentation (Seminar). Pillar 2 – Interventions and Evidence (methodological issues/other) 31 Building bridges across Canada: advancing post-COVID condition research, awareness, and management through long COVID web Douglas Gross1, Simon Décary2, Adeera Levin3, Maxi Miciak1, Susan Law4, Xiaoshu Cao5, Angela Cheung4,5 1University of Alberta, Edmonton, Canada; 2Universite de Sherbrooke, Sherbrooke, Canada; 3University of British Columbia, Vancouver, Canada; 4University of Toronto, Toronto, Canada; 5University Health Network, Toronto, Canada BMC Proceedings 2026, 20(29):31 Seminar In 2023, 2.1 million Canadians were estimated to have post-COVID condition (Long COVID), posing significant health, social, and economic challenges. Established in 2023 with CIHR funding, the Long COVID Web (LCW) aim to address knowledge gaps by 1) enhancing understanding and awareness, 2) improving care and management, and 3) promoting equitable access to Long COVID treatments and resources. LCW’s vision is “Canada free of Long COVID”, with mission focuses on four strategic objectives:Accelerating Canadian-led research on Long COVID to uncover mechanisms and biomarkers.Developing a learning health system that centers on the needs and experiences of individuals with Long COVID.Identifying optimal therapeutics, policies and practices while ensuring equitable access to care across Canada.Conducting rigorous surveillance to assess and address the personal, societal, and economic impacts of Long COVID. Accelerating Canadian-led research on Long COVID to uncover mechanisms and biomarkers. Accelerating Canadian-led research on Long COVID to uncover mechanisms and biomarkers. Developing a learning health system that centers on the needs and experiences of individuals with Long COVID. Developing a learning health system that centers on the needs and experiences of individuals with Long COVID. Identifying optimal therapeutics, policies and practices while ensuring equitable access to care across Canada. Identifying optimal therapeutics, policies and practices while ensuring equitable access to care across Canada. Conducting rigorous surveillance to assess and address the personal, societal, and economic impacts of Long COVID. Conducting rigorous surveillance to assess and address the personal, societal, and economic impacts of Long COVID. The network grows to over 1,000 members—researchers, clinicians, people with lived experience (PWLE), and decision-makers—organized into four pillars: basic/translational, clinical, health services, and population health research. LCW is supported by an array of individuals and committees including PWLE, equity/diversity/inclusion experts, Indigenous representatives, knowledge mobilization and impact experts, and an international advisory board to ensure the network can execute timely responses to current and emergent challenges. Central to LCW’s work is engaging PWLE, including children, older adults, individuals of various sex, gender, and racial/ethnic backgrounds, and family caregivers. The network’s research is guided by:Diagnostics and Assessment: How can Long COVID be diagnosed more effectively, and what biomarkers or mechanisms can aid in this process?Management and Treatment: What therapeutic targets can inform pharmaceutical and rehabilitation interventions?Access to Care: How can integrated care pathways be established to harmonize Canada’s response to Long COVID’s widespread impacts? Diagnostics and Assessment: How can Long COVID be diagnosed more effectively, and what biomarkers or mechanisms can aid in this process? Diagnostics and Assessment: How can Long COVID be diagnosed more effectively, and what biomarkers or mechanisms can aid in this process? Management and Treatment: What therapeutic targets can inform pharmaceutical and rehabilitation interventions? Management and Treatment: What therapeutic targets can inform pharmaceutical and rehabilitation interventions? Access to Care: How can integrated care pathways be established to harmonize Canada’s response to Long COVID’s widespread impacts? Access to Care: How can integrated care pathways be established to harmonize Canada’s response to Long COVID’s widespread impacts? Over the past two years, LCW has made significant progress, including the prioritization of research themes, the funding of foundational and seed research projects, and the coordination of interdisciplinary studies and clinical trials. The network hosts an annual national conference and other knowledge mobilization activities, which have connected interested partners, shared emerging evidence, and informed personal, practice, and policy decisions. LCW is also assessing its impact, having developed a fit-for-purpose conceptual impact framework and logic model to focus performance monitoring and formative and summative evaluations. We will highlight Long COVID’s early accomplishments and reflect on the lessons learned. These include successes in advancing Long COVID research, challenges encountered in addressing data gaps and methodological issues, and opportunities for improvement in fostering equitable care pathways. The insights gained from LCW’s work and impact offer valuable contributions to the global conversation on evidence-based responses to healthcare emergencies and provide a model for tackling complex health challenges within diverse populations. Discussion examples:Amongst participants, are there other experiences of how to organize to address evidence gaps for Long COVID?What lessons from addressing the evidence gaps for Long COVID could apply to future pandemics?How have others stimulated cross-jurisdictional and cross-disciplinary collaboration to advance research and improved care in response to pandemics? What works and why? Amongst participants, are there other experiences of how to organize to address evidence gaps for Long COVID? Amongst participants, are there other experiences of how to organize to address evidence gaps for Long COVID? What lessons from addressing the evidence gaps for Long COVID could apply to future pandemics? What lessons from addressing the evidence gaps for Long COVID could apply to future pandemics? How have others stimulated cross-jurisdictional and cross-disciplinary collaboration to advance research and improved care in response to pandemics? What works and why? How have others stimulated cross-jurisdictional and cross-disciplinary collaboration to advance research and improved care in response to pandemics? What works and why? Objectives Long COVID Web (LCW) is a national CIHR-funded research network established in 2023 to address the significant health, social, and economic challenges posed by post-COVID condition (also known as Long COVID), affecting 2.1 million Canadians. LCW’s mission is to: (1) accelerate Canadian-led Long COVID research, (2) develop a learning health system centered on people with lived experience (PWLE), (3) identify optimal therapeutics, policies and practices while promoting equitable access to care, and (4) conduct rigorous surveillance of Long COVID’s impacts. These objectives aim to reduce the burden of Long COVID and create a Canada free of the condition, fostering equitable responses across Canada’s diverse population. Methods LCW operates through four scientific pillars: basic/translational research, clinical research, health services research, and population health. The network comprises over 1,000 members, including researchers, clinicians, PWLE, and decision-makers. Supporting these pillars are interdisciplinary committees focused on equity, Indigenous representation, and knowledge mobilization. Research priorities, informed by PWLE via a Patient Advisory Council, encompass diagnostics, therapeutic development, and access to integrated care pathways. LCW is also assessing its impact, having developed a fit-for-purpose conceptual impact framework and logic model to focus performance monitoring and formative and summative evaluations. Results Over two years, LCW has achieved several milestones: (1) prioritized research themes and funded foundational and seed projects, with 3.4 million contributed to supporting 48 projects, (2) coordinated interdisciplinary studies addressing Long COVID diagnostics, treatments, and care access, and (3) hosted two annual national conferences and various knowledge mobilization activities, engaging diverse partners. The network’s activities have informed personal, practice, and policy decisions, advanced diagnostic biomarkers, and promoted therapeutic trials, and fostering collaboration across Canada. Conclusions LCW’s efforts have provided significant insights into Long COVID, highlighting successes in advancing research, addressing data challenges, and promoting equitable care. Lessons learned emphasize the importance of patient-centered approaches and engagement of patient partners, interdisciplinary collaboration, and inclusive methodologies. These contributions offer a model for addressing complex healthcare emergencies in diverse populations, supporting the global call for evidence-based, equitable responses to future health crises. Editorial Comments: Accepted for oral presentation. (Seminar). Other 32 Loneliness during the COVID-19 pandemic in Indigenous communities in the Northwest Territories, Canada Fariba Kolahdooz1, Moutasem Zakkar1, André Corriveau2, Kami Kandola3, Debbie DeLancey4, Sami Pirkola5, Gary Ferguson6, Arja Rautio7, Carolyn Gotay8, Adrian Wagg1, Stephanie Irlbacher-Fox9, Sangita Sharma1 1University of Alberta, Edmonton, Canada; 2Independent Public Health Consultant for the Northwest Territories and Nunavut, Yellowknife, Canada; 3Department of Health and Social Services, Government of the Northwest Territories, Yellowknife, Canada; 4Aurora College, Yellowknife, Canada; 5Tampere University, Tampere, Finland; 6Washington State University, Seattle, USA; 7University of Oulu, Oulu, Finland; 8University of British Columbia, Vancouver, Canada; 9Hotıì ts’eeda. Northwest Territories SPOR SUPPORT Unit, Yellowknife, Canada BMC Proceedings 2026, 20(29):32 Objectives The COVID-19 pandemic has had a detrimental impact on the health and well-being of individuals globally. Public health interventions aimed at mitigating the pandemic’s spread, such as social distancing, school closures, and working from home, have been linked to increased feelings of loneliness. Job loss and business closure exacerbated the issue. Loneliness refers to self-perceived isolation and dissatisfaction with the quality of social connections, and it may be a risk factor for mental ill health. Northwest Territories (NWT), a northern territory in Canada, spans 1.2 million square kilometres and has a population of 41,135, with Indigenous peoples comprising 51% of the population. Due to its vast area, geographic remoteness, and transportation challenges, social isolation has significantly impacted the quality of life for its residents. This project investigated the lived experiences of loneliness during the COVID-19 pandemic and social distancing measures among Indigenous communities in the NWT. Methods This project was conducted in ten NWT communities: three large (> 1000 people), three medium-sized (300–1000 people), and four small (< 300 people). Some communities are isolated with limited road access and health cabins, while others have road access, community health centres, and one large community has a hospital. This project employed a cross-sectional, mixed-method design and convenience sampling to recruit Indigenous individuals (≥ 18 years). The community-based participatory research model was used, with a community advisory board comprising Elders, healthcare professionals, and government officials. Data were collected via semi-structured one-on-one interviews, with closed and open-ended questions covering COVID-19’s impacts on physical and mental health, health behaviours, healthcare access, and people’s lived experiences. The questionnaire included one close-ended question regarding loneliness experience: “How has the pandemic affected your feelings of loneliness?” which was followed by an open-ended question for further explanation. Descriptive statistics and deductive thematic analysis were used for data analysis. Results Of the participants (n=287), 66.55% were women, 53.00% were 30 to 49 years old, and 72.47% identified as First Nations and 21.60% as Inuit. Most participants (74.48%) reported very good perceived health status, 34.86% reported no change in feelings of loneliness compared to before the pandemic, and 33.45% reported feeling more or much more lonely. Six themes emerged from the qualitative data: pre-pandemic social isolation, associated factors and aspects of social isolation, feelings of loneliness, outcomes of loneliness and coping with loneliness. Lockdown measures, voluntary social avoidance, and limited social gatherings and connections were reported as factors potentially contributing to loneliness, with depression and anxiety reported as outcomes. Participants utilized several strategies to cope with harmful impacts of the pandemic and social distancing and isolation, including social media, engaging with family at home, self-reflecting, and going to the land. Conclusions Public health measures and individual responses to perceived COVID-19 risks may have exacerbated isolation and loneliness among Indigenous communities in NWT, potentially harming mental health. Consequently, public health emergency measures in remote areas, including Indigenous communities in NWT and globally, should facilitate coping strategies with social isolation and develop interventions to sustain individuals’ connections to community and culture. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence 33 Exploration of evidence-based interventions targeted at reducing the risk of social frailty among older adults during times of public health emergencies: a focus on what, where and how to implement Jayna Holroyd-Leduc1, Krystale Amog2, Brooklynn Fernandes1, Monika Kastner2 1University of Calgary, Calgary, Canada; 2University of Toronto, Toronto, Canada BMC Proceedings 2026, 20(29):33 Workshop Older adults are at increased risk for social frailty, where the social factors of a person’s life can combine negatively with physical and cognitive factors to increase their risk for adverse outcomes as they age. During the COVID pandemic, the prevalence of social frailty increased due to mandated social distancing and isolation. However, promising interventions could be utilized in the future to decrease this risk of social frailty among older adults during public health emergencies. A recent systematic scoping review conducted by our team (published in BMC Geriatr 2024) identified social frailty interventions that may be feasible for use during public health emergencies. During this workshop we will discuss potentially effective interventions across six categories: 1) psychological self-management; 2) self-management education; 3) leisure activity; 4) physical activity; 5) information communication technology; 6) social assistive robots and computer agents. We will explore the potential effect of various interventions on improving outcomes related to loneliness, social isolation and social vulnerability among older adults. Given the growing interest within the general public around incorporating the use of robotics into the care for older adults, we will also review the evidence from a recent scoping review (unpublished) that explored the barriers and facilitators to incorporating robotic pets into care. We will focus on robotic pets specifically given their increasing availability and affordability, combined with the fact there is growing evidence to support their use among persons living with frailty. This will lead to a more general discussion of the potential barriers and facilitators to implementing social frailty interventions using the COM-B (capability, opportunity, motivation aspects of behaviour change) model. From this workshop, attendees will be guided toward thinking about what social frailty interventions to implement in different contexts, as well as what implementation strategies to employ in order to address key identified barriers. Workshop Objectives: To examine interventions targeted at reducing the risk for social isolation and frailty during times of public health emergenciesTo consider the context in which different intervention types may be usefulTo discuss potential barriers and facilitators to the implementation of social frailty interventions To explore strategies for implementing social frailty interventions that address key barriers To examine interventions targeted at reducing the risk for social isolation and frailty To examine interventions targeted at reducing the risk for social isolation and frailty during times of public health emergencies during times of public health emergencies To consider the context in which different intervention types may be useful To consider the context in which different intervention types may be useful To discuss potential barriers and facilitators to the implementation of social frailty To discuss potential barriers and facilitators to the implementation of social frailty interventions interventions To explore strategies for implementing social frailty interventions that address key To explore strategies for implementing social frailty interventions that address key barriers barriers Learning Outcomes:To understand the current evidence for interventions aimed at preventing social frailty during times of public health emergenciesTo develop an approach to effectively implementing social frailty interventions during public health emergencies To understand the current evidence for interventions aimed at preventing social frailty To understand the current evidence for interventions aimed at preventing social frailty during times of public health emergencies during times of public health emergencies To develop an approach to effectively implementing social frailty interventions during To develop an approach to effectively implementing social frailty interventions during public health emergencies public health emergencies Editorial Comments: Accepted for Workshop presentation. Pillar 2 – Interventions and Evidence 34 Challenges faced by health policymakers in responding to the COVID-19 pandemic in Northwest Territories, Canada Moutasem Zakkar1, Fariba Kolahdooz1, Se Lim Jang1, Adrian Wagg1, Debbie DeLancey2, Stephanie Irlbacher-Fox3, Andre Corriveau4, Carolyn Gotay5, Sangita Sharma1 1University of Alberta, Edmonton, Canada; 2Aurora College, Yellowknife, Canada; 3Hotıì ts’eeda Northwest Territories SPOR SUPPORT Unit, Yellowknife, Canada; 4Independent Public Health Consultant for Northwest Territories and Nunavut, Yellowknife, Canada; 5University of British Columbia, Vancouver, Canada BMC Proceedings 2026, 20(29):34 Objectives COVID-19 exposed the fragmented nature of health systems in many countries, including Canada. While Canada’s multilevel COVID-19 response, involving national, provincial/territorial, and municipal authorities, effectively controlled the pandemic, there existed regional operational challenges. Many Indigenous community members in Northwest Territories (NWT) in Canada live in remote and isolated communities with accompanying disproportionate socioeconomic, healthcare, and transportation challenges, which may negatively affect the pandemic response. NWT implemented non-pharmaceutical interventions including closing schools and non-essential businesses, restricting outdoor and indoor gatherings, and mandating self-isolation after returning from out-of-territory travel. Although the response was strongly adhered to and successfully reduced the spread of COVID-19, it was not without challenges. Understanding these challenges is essential for enhancing future public health responses Indigenous communities in NWT and across Canada. This study explored the perspectives of NWT health policymakers on these challenges to identify strategies to strengthen public health preparedness and response. Methods This study used a qualitative descriptive design to uncover explicit themes. A community-based participatory research approach was followed, involving collaboration among researchers, Indigenous organizations, and community members. A community advisory board played a key role in planning and implementation. Policymakers from various healthcare organizations in NWT were recruited via convenience sampling methods. The Consolidated Criteria for Reporting Qualitative Research were followed. Data were collected using semi-structured interviews and covered demographics, perspectives on COVID-19 response, challenges, and future strategies. Interviews averaged 30 min. Participants provided verbal or written consent, and interviews were audio-recorded with permission. Responses were recorded in REDCap. Deductive thematic analysis was conducted, informed by the World Health Organization’s Health Emergency and Disaster Risk Management framework. Two authors independently coded the data, with a third resolving discrepancies. NVivo Pro V12 was used for qualitative data analysis. Results The participants interviewed (n=56) held several managerial roles, including public health (64.3%) and community service management (26.8%). Participants worked in territorial organizations (71.7%), regional organizations (14.3%), and community organizations (14.3%). Qualitative data revealed four key themes representing the challenges faced by policymakers: Governance challenges included unclear roles and responsibilities, policy lagging, gaps between policy and frontline operations, and limited community consultation. Risk communication challenges included the complexity of information and language barriers. Community-level challenges included people’s compliance level with public health measures, the communities’ distrust of the health system, and geographic barriers. Health system challenges included limited human resource capacity, information technology challenges, the absence of robust information systems, and limited material resources. Conclusions Health policymakers in NWT strived to respond to the COVID-19 pandemic addressing challenges related to governance, communication, community, and the health system. Building a resilient health system capable of predicting, adapting to, and responding to future public health pandemics, while maintaining essential health services, requires several key actions. These include clearly defining roles and responsibilities during public health emergencies, fostering collaboration among policymakers, frontline healthcare providers, and community leaders, developing efficient and effective data infrastructure, and enhancing both infrastructural and human resource capacities within the health system. Equally critical is ensuring effective communication with communities and rebuilding trust in the health system among community members. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence 35 Modelled evidence addressing non-pharmacological interventions for viral respiratory infections: a scoping review protocol Jessica J. Bartoszko1,2, Adam S. Komorowski1,2,3,4,5, Jenine Leal2,6,7,8,9, Yuan Zhang1,2,10, Mark Loeb1,2,3,5 1Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada; 2Pandemic EVIDENCE Collaboration, Oxford University, Oxford, UK; 3Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada; 4Microbiology Department, Hamilton Regional Laboratory Medicine Program, Hamilton, Canada; 5Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Canada; 6Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada; 7Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Canada; 8O’Brien Institute of Public Health, Cumming School of Medicine, University of Calgary, Calgary, Canada; 9Infection Prevention & Control, Alberta Health Services, Edmonton, Canada; 10Department of Health Sciences, Brock University, St. Catherines, Canada BMC Proceedings 2026, 20(29):35 Background During the COVID-19 pandemic, decision-makers relied on modelled evidence to inform policy and action on non-pharmacological interventions (NPIs). The objectives of this scoping review are to summarize the methodological characteristics and quality of epidemiologic modelling studies addressing NPI effectiveness against viral respiratory infection transmission. Methods MEDLINE, Embase, MathSciNet and the Living Overview of Evidence online platform, along with citations of included studies, will be searched from inception for studies published as peer-reviewed articles that predict the effect of NPIs on viral respiratory infection transmission. Eligible NPIs may include masking, physical distancing, quarantine upon arrival from travel and school closures. Viral respiratory infections caused by World Health Organization priority pathogens for pandemic preparedness (e.g., SARS-CoV-2, influenza A H5N1) may be eligible. Transmission outcomes may include the reproductive number and rate of incident infections. Studies of statistical models used to estimate the associations between measured variables (i.e., regression models) will be excluded. Screening and data extraction will be completed independently and in duplicate. Collected data will include bibliographic (e.g., year of study publication) and methodological characteristics (e.g., model inputs). Reviewers will use Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidance conceptualized for modelled evidence to assess the certainty of evidence from included studies. The GRADE assessment will include considerations for risk of bias (e.g., confidence in model inputs), inconsistency (e.g., consistency of model inputs ascertained from the literature), imprecision (e.g., whether or not the modeling study included information about the output variability), indirectness (e.g., degree to which the model output was discrepant with the decision question in terms of the intended population, intervention, time horizon and outcome), and publication bias (e.g., if the single model was not constructed de novo, likelihood that relevant models have been constructed but were not published or made publicly available). We will report results as total numbers, frequencies, and percentages for categorical variables and medians and interquartile ranges for continuous variables that are not normally distributed. Discussion This study has several strengths compared to previous reviews: inclusion of viral respiratory infections beyond COVID-19; a comprehensive search strategy; no time restriction to the early phase of the COVID-19 pandemic; and application of novel GRADE guidance for modelled evidence. This overview of the current landscape may help standardize methods for the conduct, reporting and quality assessment of transmission modelling studies, and inform future generation of high-quality modelled evidence for NPIs and emerging pathogens. Keywords: Epidemiological modelling; Mathematical modelling; Non-pharmacological interventions; Emerging pathogens; Viral respiratory infections; Pandemic; Protocol; Systematic review Editorial Comments: Accepted for oral presentation (protocol only). Pillar 2 - Interventions and Evidence 36 The impacts of COVID-19 on children’s health behaviour and well-being in Northwest Territories Moutasem Zakkar1, Fariba Kolahdooz1, Adrian Wagg1, Debbie DeLancey2, Sami Pirkola3, André Corriveau4, Henry Conter5, Sangita Sharma1 1University of Alberta, Edmonton, Canada; 2Aurora College, Yellowknife, Canada; 3Tampere University, Tampere, Finland; 4Independent Public Health Consultant, Yellowknife, Canada; 5Hoffman-La Roche Limited, Mississauga, Canada BMC Proceedings 2026, 20(29):36 Objectives The COVID-19 pandemic has impacted children’s health, education, and behaviour globally. Lockdowns and school closures reduced physical activity and increased screen time. In Canada, families faced economic and mental health challenges, with high rates of depression and anxiety among mothers and children. Children were concerned about family health, stress, and substance use. Northwest Territories (NWT) in Canada, with a 1.2 million square kilometres land area and a population of 41,135 (51% Indigenous), faces educational challenges due to community remoteness, small schools, and limited teachers. Limited health services and transportation difficulties have significantly affected residents’ quality of life. COVID-19 public health measures led to social isolation and education disruptions, worsening educational outcomes. Remote learning challenges are expected to have long-term impacts post-pandemic. Despite extensive research on COVID-19, the socioeconomic, educational, and psychological impacts remain underexplored. This project examines NWT parents’ perspectives on COVID-19’s effects on children’s health, behaviours, and well-being. Methods This project involved 11 NWT communities, including large (> 2000 people), medium-sized (550–2000 people), small (< 550 people), and very small (< 150 people) populations. Indigenous community members comprised 23%−97% of these communities. Six communities had year-round road access, while others were isolated. Healthcare services varied from health cabins to community health centres and one hospital. This project used a convergent parallel mixed methods design with convenience sampling. Participants were Indigenous community parents/guardians of children. Data were collected Data were collected between August 2022 and January 2023 via a semi-structured questionnaire addressing COVID-19’s impact on health, well-being, behaviours, and healthcare access. The project employed a community-based participatory research model, with a community advisory board guiding all stages, including planning, recruitment, data collection, and dissemination. Descriptive statistics were generated, and quantitative analysis was conducted using SAS Software version 9.4. Qualitative data were analyzed through deductive thematic analysis using NVivo Pro version 12. Results Parents (n=102) were interviewed, 79.21% women; 58.42% had some high-school education, and 31.68% completed post-secondary education. Socioeconomically, 66.67% were employed, 36.63% often or sometimes ate less due to food scarcity, and 31.68% struggled to pay bills. Regarding COVID-19’s impact on children, parents reported worsened mental health (20.41%), decreased social interaction (27.55%), increased screen time (52.53%), and decreased physical activity (21.65%). Additionally, 33.94% noticed behavioural changes in children. Qualitative insights revealed that parents were primarily concerned regarding children’s health, well-being, and educational achievement. Other themes included children’s adherence to COVID-19 public health measures, the pandemic’s impact on their health behaviours, mental health, and education, as well as families’ coping strategies during the pandemic. Conclusions While public health measures aim to safeguard individuals from the direct impacts of emergencies like COVID-19, they may inadvertently affect the health and well-being of families, particularly children. In this project, parents prioritized concerns about their children’s health, well-being, and educational achievement and employed various coping strategies, including Indigenous cultural practices, to manage stress. It is crucial to consider the potential effects on children, parental concerns, and families’ coping strategies when designing and implementing public health measures to respond to health emergencies. These findings are especially important for small and remote communities globally. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence (methodological issues/other) 37 Antidepressant prescribing trends in Northern Poland: findings from the COVID-19 pandemic Pawel Zagozdzon, Anna Urban Medical University of Gdansk, Gdansk, Poland BMC Proceedings 2026, 20(29):37 Objectives The number of antidepressants prescribed in Poland has been increasing over the last several years; however, the pattern of antidepressant use during the COVID-19 pandemic was not described. This study examined trends and incidence in antidepressant prescribing in Northern Poland between 2009 and 2022. Methods The dataset used in this study included 4,754,287 refunded antidepressant drugs prescribed for a total of 412,937 patients who were registered in National Health Fund across the 13-year period. Age-standardized incidence rates (SIRs) for the use of antidepressants were calculated for each year of the study period. Standardised Mortality Ratios (SMRs) and 95% confidence intervals (CI) for those using antidepressants were also examined. Results Antidepressant prescriptions rose from 281,716 per year in 2009 to 528,494 in 2022 (87% increase). Incidence rates of those starting antidepressants remained stable in period 2009 −2020 (SIR in 2009: 10.8 per 1000; SIR in 2020: 11.6 per 1000) but increased in years 2021-2022 (SIR in 2021: 13.3 per 1000; SIR in 2022: 14.45 per 1000. The duration of treatment increased with later starting years, with an increasing proportion of long-term use, and decrease in short-term use. SIR for antidepressant use for women was doubled compared to men. SMRs remained stable during study period:. 3.58 in 2009 (95% CI 3.31−3.87) and 3.79 in 2022 (95% CI 3.53- 4.06) Conclusions The increase in antidepressant prescribing over the study period is a potential cause of concern and appears to be driven by an increase in long-term use of these medications and changes in social life in period 2020-2022. The social restrictions amid COVID-19 pandemic had implications in the use of medications for mental health including antidepressants. An accurate estimate of the potential impact of different non-pharmaceutical measures during pandemic on mental health is not possible to obtain. However, it is necessary to rethink some of the linkage mechanisms between various alternative self-isolation, social distance, social isolation, contact tracing, employment policies, vaccination mandates and depression. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence (data challenges/other) 38 Exploring mental health and learning loss of students during the COVID-19 pandemic: an international study within the EuCARE project Fedrica Bellerba1, Giulia Doi1, Elisa Tomezzoli1, Sara Raimondi1, Ilaria Cutica2, Davide Mazzoni2, Inês Martins Alves3, André Filipe Bruno de Oliveira Tomás dos Santos3, Pier Luigi Lopalco4, Valeria Gabellone4, Nils Bardeck5, Gibran Horemheb Rubio Quintanares6,7, Giuseppina Tucci8, Chiara Mommo9, Iuri Fanti9, Ana Abecasis3, Rolf Kaiser5, Francesca Incardona9, Sara Gandini1 1European Institute of Oncology, Milan, Italy; 2University of Milan, Milan, Italy; 3Universidade Nova de Lisboa, Lisbon, Portugal; 4University of Salento, Lecce, Italy; 5University of Cologne, Cologne, Germany; 6Paul Ehrlich Institut, Langen, Germany; 7Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico; 8Organising Bureau of European School Student Unions (OBESSU), Brussels, Belgium; 9EuResist Network, Rome, Italy BMC Proceedings 2026, 20(29):38 Objectives The COVID-19 pandemic highlighted the urgent need for evidence-based strategies to ensure safe school re-openings. To address this, we conducted an international cluster randomized controlled trial (RCT) to assess the efficacy of the Lolli-Methode as a surveillance tool in schools. Additionally, we investigated the psychological symptoms and learning loss experienced by students in relation to school closures and other preventive measures implemented during the pandemic. Methods We used the Strengths and Difficulties Questionnaire to measure psychological symptoms (Total difficulties (TD), Emotional Problems (EM), Conduct Problems (CP), Hyperactivity (HY), Peer Relationship Problems (PRP)) in students from kindergarten to high school in Italy, Portugal, and Mexico. With ad-hoc questionnaires, we also measured students’ attitudes and feelings toward preventive measures, including distant learning, social distancing, masks, vaccination, and staggered school entrances. Questionnaires were collected at multiple time points between November 2022 and March 2024. For Italian students, assessments of performance in Mathematics and Italian were provided by the INVALSI institute for the school years 2018/19, 2020/21, 2021/22, and 2022/23. Associations between investigated factors, psychological symptoms and learning loss were estimated using linear mixed models. To evaluate causal relationships, mediation analysis under the counterfactual framework, incorporating effect measure modification by covariates, was performed. Results We collected 685 questionnaires from students in Italy, Portugal and Mexico, across all grades. Abnormal EM were observed in 17.4% of secondary school students, with high school students showing the highest levels (p<0.01). EM were higher in girls in middle (p for interaction=0.03) and high school (p for interaction < 0.001) and in those reporting a negative experience with social distancing (< 0.001). PRP also increased with age (p<0.001) and were higher in those with a recent experience of Distant Learning (p=0.02). TD were associated with negative social distancing experiences (p<0.001). Girls reported a worse experience with Distant Learning, leading to greater TD compared to boys (Total Natural Indirect Effect: p=0.03). In Italy, performance in Mathematics and Italian decreased during the pandemic years compared to the pre-pandemic period across all grades, with greater learning loss in students from low socio-economic backgrounds (p=0.05) and those whose mothers had low educational levels (p=0.01). Conclusions Our findings showed that pandemic-related preventive measures had a significant impact on students’ mental health, with distant learning playing a particularly detrimental role. Girls reported a worse experience with distant learning, resulting in greater psychological difficulties compared to boys. Additionally, mental health, socio-economic status, and maternal educational level played a key role in the learning loss observed among Italian students during the pandemic. These results underscore the importance of prioritizing students’ mental health in the post-pandemic debate and ensuring that educational policies address inequalities exacerbated during this period. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence (data challenges) 39 Assessing the effectiveness of continuous masking policies in reducing transmission of respiratory infections: a systematic review Qandeel Shafqat1,2, Elissa Rennert-May2,3,4,5,6, Stephanie Smith7,8, Devika Dixit9,10, Connor Rutherford3, Jessalyn Almond3, Oscar Larios3,5,6, John Conly2,3,4, Jenine Leal2,3,4,5 1Undergraduate Medical Education, University of Calgary, Calgary, Canada; 2Department of Community Health Sciences, University of Calgary, Calgary, Canada; 3Infection Prevention and Control, Alberta Health Services, Calgary, Canada; 4O’Brien Institute for Public Health, University of Calgary, Calgary, Canada; 5Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada; 6Department of Medicine, University of Calgary, Calgary, Canada; 7Infection Prevention and Control, Alberta Health Services, Edmonton, Canada; 8Department of Medicine, University of Alberta, Edmonton, Canada; 9Department of Pediatrics, Division of Infectious Diseases, Calgary, Canada; 10Workplace Health and Safety, Alberta Health Services, Calgary, Canada BMC Proceedings 2026, 20(29):39 Objectives Respiratory viral infection (RVI) outbreaks pose a significant threat to health. They are associated with patient morbidity and mortality, healthcare worker absenteeism, and a substantial financial burden on the healthcare system. There is a need for strategies to reduce RVI transmission in hospitals. One proposal is implementation of mandatory continuous masking policies. Despite the widespread use of such policies during viral outbreaks, the effectiveness of continuous masking in mitigating the spread of respiratory infections remains uncertain. Consequently, there are inconsistencies in masking policies issued by healthcare organizations. Moreover, the lack of robust evidence poses a challenge to our preparedness for outbreaks like seasonal influenza, respiratory syncytial virus, COVID-19, and other respiratory viruses. Therefore, we aimed to conduct a systematic review of the literature to determine the effectiveness of continuous masking in reducing the incidence and transmission of RVIs amongst patients and healthcare workers (HCWs) in hospital settings. Methods We systematically searched the following electronic databases for original research articles published between January 1, 2000 – May 31, 2024 according to a pre-determined search criterion: Ovid Medline, Embase (including MedRXiv preprints), EBM Reviews-Cochrane Central Register of Controlled Trials, EBM Reviews-Cochrane Database of Systematic Reviews, CINAHL on Ebsco, Web of Science (grey literature). Studies were retrieved and screened by two independent reviewers in Covidence. The Joanna Briggs Institute critical appraisal tools will be used for risk-of-bias assessment. One reviewer extracted the data from selected studies according to a pre-determined data extraction form, and two independent reviewers validated the data extracted. Meta-analysis to pool unadjusted or adjusted outcome measures for studies that report a statistical comparison between masking policies and transmission of infections will be considered if appropriate based on heterogeneity. For studies that reported only count data (e.g., number of events) where no statistical comparison was made, results were summarized narratively. Results Of the 3691 studies identified, 17 met eligibility criteria. 12 studies were conducted in single-center adult hospitals. 4 studies were conducted in pediatric hospitals, with 2 of those in neonatal centers. One study was conducted on a hospital system. Various infections were included in the studies, including influenza A and B, parainfluenza 1–3, adenovirus, respiratory syncytial virus (RSV), traditional human coronavirus strains, human metapneumovirus, SARS-CoV-2, and rhinovirus/enterovirus. Eight of the studies assessed the impact of a masking policy on infection rate in patients. All 8 of these studies reported that masking policies reduce transmission of infection in patients. Of 9 studies which assessed the impact of a masking policy on infection rate in HCWs. 7 of these studies were associated with reductions in infection transmission in HCWs, whereas 2 studies showed no statistically significant change in infection transmission in HCWs. Conclusions The studies identified in this systematic review were associated with a reduction in RVI transmission with the use of continuous masking amongst patients. The evidence for continuous masking was less consistent for preventing RVI transmission amongst HCW with two studies reporting it was not effective. Our findings suggest that masking policies may play a role in VRI prevention but there are significant limitations with the use of observational design and the use of masking in conjunction with other prevention measures. However, assessment of the quality of the papers is pending. Future directions will include assessing secondary outcomes such as masking adherence and patient morbidity and mortality and assessing adjusted analyses form confounding which are critically important. Editorial Comments: Accepted for poster presentation. Pillar 3 - Practice and Policy 40 Inequalities in Scotland’s response to the COVID-19 pandemic Kieren Egan, Ruaridh Clark, Paul Flowers University of Strathclyde, Glasgow, UK BMC Proceedings 2026, 20(29):40 Pandemics bring an array of negative consequences that affect some people more than others. Consequences that are challenging to foresee given the complex interactions within ecosystems between people, microbes and other animals. During the pandemic, we collectively failed to make sure that our attempts to control the disease also addressed inequalities from the outset. Including the disproportionate impact on certain ethnic communities more than others, where those with the lowest income were worst affected. We already know that making sure we reduce inequalities in future epidemics will be a challenge. We need the public, affected communities, the health and social care system, national and international governments to work together and do things differently than we have done in the past. ‘Doing things differently’ will require new kinds of research and demand new ways of thinking about research questions. As such we need different academic disciplines to share their expertise and insights in order to deliver new ways of thinking to help shape future responses to coming epidemics. An interdisciplinary approach to preparing for future epidemics/pandemics requires additional time and effort. Therefore, it is only in this window following a previous major pandemic that we can prepare comprehensively rather than react efficiently. Our interdisciplinary approach is seeking to challenge issues such as the hierarchy of evidence, where the pandemic showed that certain forms of evidence – e.g. types of physics models and statistical analysis – were given greater credence than others – e.g. documented lived experience. We have sought to develop mosaics of evidence by collating disciplinary perspectives on how oversights in pandemic preparedness led to instances of inequality. These disciplinary perspectives were then interrogated in an interdisciplinary forum that followed a series of principles to counter perceived hierarchies and enable equitable contributions. Case studies of inequalities were collated by the Poverty Alliance, an anti-poverty and research-active network of organisation and communities. For each case study, a range of possible shortcoming in preparedness have been identified from a disciplinary perspective. The complex interactions between these shortcomings in preparedness have then been interrogated through an interdisciplinary lens to produce a series of recommendations and focal points for where interdisciplinary research can have a distinct impact beyond efficient and conventional multidisciplinary approaches This work aligns and engages with national initiatives in Scotland to learn from COVID-19 and prepare for future pandemics. The work highlights that a flaw in the preparation and reaction to COVID-19 was the near-exclusive prioritisation of medical input and perspectives. Future pandemics requiring that inequalities and social impacts are given similar weighting to medical considerations to ensure better immediate and especially long-term impacts from the next pandemic. Editorial Comments: Accepted for poster presentation. Pillar 2 - Interventions and Evidence 41 Uncovering the consequences of additional precautions on patients and healthcare workers in acute care settings: a scoping review Prakriti Pathania1, Jillian Cannon1, Jenine Leal1,2, Stephanie Smith3 1University of Calgary, Calgary, Canada; 2Alberta Health Services, Calgary, Canada; 3Alberta Health Services, Edmonton, Canada BMC Proceedings 2026, 20(29):41 Objectives Additional precautions are used in acute care settings to prevent transmission of pathogens between patients and between healthcare workers and patients. These include patient isolation and the use of personal protective equipment (PPE). Although considered standard practice for high-quality care and patient safety, an enhanced understanding of how additional precautions can impact the experiences of patients, healthcare workers, and the healthcare system is needed. This scoping review intends to uncover the costs and consequences involved in implementing additional precautions on patient and healthcare worker experiences as well as outcomes on healthcare systems, such as patient flow. The secondary objective is to assess whether additional precautions’ benefits and consequences differ by sociodemographic factors contributing to health inequity. Methods Guided by the Joanna Briggs Institute Manual for Evidence Synthesis and PCC (population, concept, context) framework, a scoping review was conducted. Studies focused on the use of additional precautions in hospital settings, and impacts to patients, patient’s families, healthcare workers, and the healthcare system. Online databases searched included Medline (OVID), Embase, CINAHL, Cochrane library, and SCOPUS. A grey literature search was not conducted. The search strategy included terms related to additional precautions, inpatients, healthcare workers, acute care, isolation measures, transmission precautions, and PPE. Two reviewers completed the title and abstract reviews independently and met to discuss discrepancies. Two reviewers then performed the full-text screening and using the selection of relevant sources the reviewers will conduct a narrative summary. Included sources will also be evaluated through the lens of PROGRESS-Plus to assess whether the studies accounted for equity considerations. Results Of the 14,875 titles and abstracts screened, 280 full-texts were assessed, resulting in 189 studies included for data synthesis. Study designs identified included observational studies (n=70), qualitative studies (n=51), cost-analysis studies (n=35), retrospective cohort studies (n=13), experimental studies (n=6), mixed methods studies (n=5), correlational studies (n=5), pilot studies (n=2), and environmental impact studies (n=2). There were 67 studies from North America, Europe (n=64), Asia (n=34), Australia (n=16), Africa (n=4), South America (n=2), and 2 international studies. Preliminary synthesis of outcomes revealed costs of additional precautions, adverse skin reactions to PPE, isolation related distress, healthcare worker burnout due to precautions, and environmental impacts of PPE. Comprehensive narrative synthesis of outcomes and impacts of additional precautions across equity characteristics is in progress. Conclusions This study aims to broaden the understanding of the impact that implementing additional precautions in acute care has on the experiences of patients, HCWs, and the healthcare system. Bridging the gaps in this area of research can help direct future practices to accommodate new findings. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 – Interventions and Evidence (methodological issues/other) 42 The utility of trending serial cycle threshold values for SARS-COV-2 allowing for early de-isolation and cost savings from unnecessary use of PPE and bed blocking Heidi O’Grady1, Elissa Rennert-May2, Leal Jenine2,3, Roxanne Lyachovics1, Isabelle Tremblay1, Hitesh Patel1, Osariemhen Attamah1, Louise Curammeng1, Jessalyn Almond1, Vinita Kumar1, Jamil Kanji2,4, John Conly1,2 1Infection Prevention and Control, Foothills Medical Centre, Alberta Health Services, Calgary, Canada; 2University of Calgary, Calgary, Canada; 3Infection Prevention and Control, Standards and Surveillance, Alberta Health Services, Calgary, Canada; 4Infection Prevention and Control, Royal Alexandra Hospital, Alberta Health Services and Control, Foothills Medical Centre, Alberta Health Services, Edmonton, Canada BMC Proceedings 2026, 20(29):42 Introduction/Objectives There are increasing numbers of studies assessing cycle threshold (Ct) values and the association with cultivatable SARS-CoV-2 which may be considered a reliable surrogate for infectiousness; i.e. the ability to transmit infectious virus associated with COVID-19. The magnitude of the Ct value and the trending in immunocompetent patients can facilitate confidence in decision making regarding transmission events and isolation decisions. We sought to assess use of trending analysis of serial Cts along with relevant clinico-epidemiologic data from patients who had testing done for suspected COVID-19 in the healthcare setting and its ability to provide discontinuation of isolation and what may be the potential cost savings. Methods Nasopharyngeal or other respiratory samples were collected from suspected community- or hospital-acquired COVID-19 patients with compatible symptoms from a single 1100 bed hospital using convenience sampling during 2024. RT-PCR assays employed included multiple commercially available assays or an in-house assay using predominantly E, N and/or RdRp gene primers using internal controls. In the absence of progressive symptoms, follow-up swabs were obtained within 1–4 days and with the same platform whenever possible. The presence of a stable increasing, or negative Ct value and clinical assessment was used to immediately discontinue isolation. A literature review identified a Ct value of 30 equated to non-cultivatable virus across multiple platforms. Costs of contact isolation, available from a previous local study and additional data on masks and PCR assays allowed assessment of the total costs and potential cost savings with the de-isolation intervention. All costs were inflation adjusted to 2024. Results We identified 12 patients over 6 months who met the criteria and were de-isolated within 1–4 days versus a traditional 11-day isolation period normally used. No transmission events were identified in any case of de-isolation. Isolation costs/day were $304.85 and $ 441.62 for use of a surgical mask or a N95 respirator, respectively for contact/droplet precautions. An average savings of 8 isolation days provided an estimated savings of $2388.80 – $3482.96/pt and applying this to 558 patients/year across the 2 largest health regions in our province (based on 7.2% of patients meeting the criteria from one site with complete data) leads to a maximal savings of $1.94 million/year. Avoiding isolation is associated with greater contact by HCWs, less bed blocking, less risk of psychological harm, delirium, deconditioning and mental health deterioration and less environmental pollution from the discarding of unnecessary surgical masks, N95 respirators and gloves. Conclusions We have identified the potential for utilization a trending analysis of serial Ct values and believe the systematic application of this process could optimize patient care of COVID-19 patients by ensuring appropriate and timely isolation while minimizing unnecessary restrictions and personal protective equipment associated costs while also reducing the risk of infection transmission. When available and appropriate, use of serial Ct values can be used to guide isolation decisions, alongside clinical symptoms. A formal cost-effectiveness analysis would be of considerable value to further explore this strategy. Editorial Comments: Accepted for poster presentation. Pillar 3 - Practice and Policy 43 Accelerated evidence synthesis and dashboard science for pandemic prevention and response: lessons from real-world initiatives at the University of Calgary’s Centre for Health Informatics Mairead Whelan, Guosong Wu, Harriet Ware, Danielle Southern, Elissa Rennert-May, Jenine Leal, Tyler Williamson University of Calgary, Calgary, Canada BMC Proceedings 2026, 20(29):43 Workshop Effective pandemic prevention and response requires robust evidence generation and synthesis to inform decision-making with data and methods that balance reliability and efficiency. During the COVID-19 pandemic and beyond, the University of Calgary’s Centre for Health Informatics (CHI) innovation hub of data experts, software developers, and public health professionals placed Calgary at the forefront of infectious disease tracking at a provincial, national, and global stage. This 90-min workshop explores applied approaches researchers can use to accelerate evidence synthesis for pandemic preparedness, including dashboard mapping tools, interactive living systematic review methodology, and using artificial intelligence to automate evidence synthesis across various topics. The workshop will feature case studies from the University of Calgary’s Centre for Health Informatics (CHI), including: 1) CHI’s early development of the Alberta COVID-19 case tracker and wastewater surveillance dashboard; 2) an interactive session and live demo on SeroTracker, including a map dashboard and data tool to explore seroprevalence studies for SARS-CoV-2, six arboviruses, and Middle East Respiratory Syndrome; 3) SeroTracker’s methodology to streamline living systematic review execution, including a landmark Artificial Intelligence (AI) prompting framework showing 90% efficacy in automating systematic review screening, related initiatives using AI and non-pharmaceutical intervention (NPI) evidence generation, and how it can be applied across a variety of subjects; and 4) A discussion session on current challenges in mobilizing reliable and standardized evidence to implement pandemic interventions. Through interactive discussions, presentation of research results, tool demonstrations, and practical case studies, attendees will learn to integrate these approaches into their work, enhancing the rapid generation of actionable insights during health crises. Learning Outcomes and Objectives Outcome 1: Explore opportunities to integrate dashboard science into communicating pandemic evidence and research outcomes. Objective 1a: Explore available dashboard services for pandemic and public health utility at the CHI, featuring the COVID-19 and wastewater tracker. Objective 1b: Complete a live interactive demo of SeroTracker’s dashboard so attendees can comfortably use the platform’s tools to explore downloadable epidemiological data and understand its use cases for knowledge translation. Outcome 2: Equip attendees with new approaches to evidence synthesis that can be applied to attendees’ own research, policy-making, or question generation. Objective 2a: Explore the methodology and innovative evidence synthesis strategies behind SeroTracker’s dashboard and living systematic review. Objective 2b: Compare tools to automate systematic reviews using Artificial Intelligence and teach attendees how they may apply these topic-agnostic approaches on their own Outcome 3: Collaborate with peers to identify gaps in current evidence-generation practices and brainstorm innovative solutions for future pandemics. Objective 3a: Discuss the role of evidence synthesis in evaluating non-pharmaceutical interventions (NPIs) in pandemic mitigation, infection detection, and other healthcare outcomes, including evidence-based strategies for assessing their effectiveness. Objective 3b: Brainstorm challenges, solutions, and next steps for the future of pandemic evidence synthesis. Objectives Outcome 1: Explore opportunities to integrate dashboard science into communicating pandemic evidence. Objective 1a: Review dashboard services for pandemic and public health utility at the CHI, featuring the COVID-19 and wastewater tracker. Objective 1b: Interactively demo SeroTracker’s dashboard so attendees can use tools to explore downloadable data and apply use cases for knowledge translation. Outcome 2: Equip attendees with approaches to evidence synthesis. Objective 2a: Review methodology and innovative evidence synthesis strategies behind SeroTracker’s dashboard and living systematic review. Objective 2b: Compare tools to automate systematic reviews using AI and teach attendees to apply these approaches on their own work Outcome 3: Collaborate with peers to identify gaps in evidence-generation practices and brainstorm solutions. Objective 3a: Discuss the role of evidence synthesis in evaluating non-pharmaceutical interventions (NPIs), including strategies for assessing their effectiveness. Objective 3b: Brainstorm challenges, solutions, and next steps for the future of pandemic evidence synthesis. Methods This 90-min workshop explores applied approaches researchers can use to accelerate evidence synthesis for pandemic preparedness, including dashboard mapping tools, interactive living systematic review methodology, and using artificial intelligence to automate evidence synthesis across various topics. This workshop will utilize case studies, audience participation, interactive demos of online tools, and discussion. Results The workshop will feature case studies from the University of Calgary’s Centre for Health Informatics (CHI), including: 1) CHI’s early development of the Alberta COVID-19 case tracker and wastewater surveillance dashboard; 2) an interactive session and live demo on SeroTracker, including a map dashboard and data tool to explore seroprevalence studies for SARS-CoV-2, six arboviruses, and Middle East Respiratory Syndrome; 3) SeroTracker’s methodology to streamline living systematic review execution, including a landmark Artificial Intelligence (AI) prompting framework showing 90% efficacy in automating systematic review screening, related initiatives using AI and non-pharmaceutical intervention (NPI) evidence generation, and how it can be applied across a variety of subjects; and 4) A discussion session on current challenges in mobilizing reliable and standardized evidence to implement pandemic interventions. Conclusions Through interactive discussions, presentation of research results, tool demonstrations, and practical case studies, attendees will learn to integrate these approaches into their work, enhancing the rapid generation of actionable insights during health crises. Editorial Comments: Accepted for Workshop presentation. Pillar 2 - Interventions and Evidence 44 Correlating SARS-CoV-2 infectivity in clinical samples with cycle threshold values Yi-Chan Lin1, John Conly2, David Evans1 1Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada; 2Department of Medicine, University of Calgary, Calgary, Canada BMC Proceedings 2026, 20(29):44 Introduction/Objectives Recent data (Bruce et al 2021) have provided valuable insights into how diagnostic PCR-based tests might be used to predict the SARS-CoV-2 infectiousness, reporting that neither a previously published virus negative-strand RNA assay nor a virus subgenomic RNA assay offered any advantages. A receiver operating characteristic (ROC) curve demonstrated that the best practical tool used quantitative RT-PCR, E-gene primers, and a Cycle threshold (Ct) cutoff of 31.0 [95% True Positive Rate (TPR) and 61% Positive Predictive Value (PPV)]. The utilized E gene RNA, negative‐strand RNA, and two subgenomic RNA primer‐probe sets may not be as widely used as the N-gene primers designed by the CDC for their SARS-CoV-2 RT-PCR assay (Anon. 2020). We therefore sought to assess how well infectivity from clinical samples on cell culture can be predicted using the CDC N-gene primers. Methods We have re-evaluated a data set we derived from > 400 clinical specimens, the vast majority of which were collected within a 7-to-8 day window following the onset of symptoms (Lin et al, 2022). The Ct was determined using a commercial RT-PCR kit (IDT Cat#10006713) and unlabelled N-gene primers with internal controls, and the virus titers (PFU/mL) were determined by plating dilutions on Vero (ATCC #CCL-81) or Vero E6/TMPRSS2 (JCRB cell bank 1819) cells. The limit of detection of the plaque assay was ~5 PFU/mL. We generated a ROC plot using GraphPad Prism (v 9.3.1) to compare cultivatability versus the N-gene Ct in a manner analogous to what was described by Bruce et al. Results We generated a ROC curve from our data (Figure 1) and found a Ct value ≤ 28.8 would predict that a specimen contained infectious virus in 95% of the infected samples (dotted line), while returning a false positive rate of 35% in uninfected specimens. Judging from DNA-templated standard curves, a Ct of 28.8 in this quantitative PCR assay is approximately 700 target copies per PCR reaction. The 95% positive predictive agreement was very similar to that observed using the total E-gene based primer gene assay (Bruce et al). The determination of Ct thresholds may be a useful surrogate to predict transmission risk and allow removal of isolation in healthcare settings. A limitation is that we assumed that the ability to culture virus on Vero E6 or Vero TMPRSS2 cells was correlated with the ability to be infectious to humans. Conclusions Our findings suggest that the CDC N gene assay would also be a valuable PCR assay, but with a different Ct cut-off and somewhat higher PPV, when judging the risk of finding cultivatable SARS-CoV-2 in specimens from acutely infected and convalescent patients. We recognize that Ct values are dependent upon the primer sets used, platform used and the laboratory in which it is performed which may be a limitation of our findings. Editorial Comments: Accepted for poster presentations. Pillar 1 - Diagnostics and Transmission Fig. 1 (Abstract 44)ROC showing the diagnostic performance of the CDC N-gene RT-PCR assay. The NPV and PPV were 72 and 75% respectively. At a Ct cut-off of > 31 no infectivity was found. ROC showing the diagnostic performance of the CDC N-gene RT-PCR assay. The NPV and PPV were 72 and 75% respectively. At a Ct cut-off of > 31 no infectivity was found. 45 Evaluating the effectiveness of the enhanced masking directive in acute care hospitals in Alberta, Canada during the 2023-2024 and 2024-2025 respiratory seasons Jenine Leal1,2,3, Elissa Rennert-May1,2,3, Ingeborg Hess Elgersma3,4, Jessica Bartoszko3,5, Kristine Cannon2, Philana Choo6, Devika Dixit1,2, Jennifer Ellison7, Mark Loeb5, Amity Quinn1, John Conly1,2,3, Qandeel Shafqat1, Oscar Larios1,2,8, Stephanie Smith2,9 1University of Calgary, Calgary, Canada; 2Alberta Health Services, Calgary, Canada; 3Pandemic EVIDENCE Collaboration, Oxford, UK; 4Norwegian Institute of Public Health, Oslo, Norway; 5McMaster University, Hamilton, Canada; 6Covenant Health, Edmonton, Canada; 7Alberta Health Services, Lethbridge, Canada; 8Alberta Precision Laboratories, Calgary, Canada; 9University of Alberta, Edmonton, Canada BMC Proceedings 2026, 20(29):45 Objectives Universal masking is the requirement to wear a medical/surgical mask by all staff (clinical and non-clinical), patients, and visitors at any time. Universal masking was implemented in Alberta as a response to the COVID-19 pandemic across all acute care hospitals. Now five years later, universal masking mandates have ceased and instead the enhanced masking directive was issued on October 20, 2023. Implementation of enhanced masking is determined by a risk assessment of indicators (e.g. outbreaks) and the situational context (e.g. service capacity). When implemented by a hospital, enhanced masking requires all acute care hospital staff to wear masks where they may encounter patients and/or designated support persons; visitors and support persons in emergency departments; and patients are not required to wear masks. The aim of the study is to evaluate the impact of the directive in preventing transmission of respiratory viruses during the 2023-2024 and 2024-2025 respiratory seasons. Methods We will use event study models to compare outcomes between acute care hospitals that implemented versus those that did not implement the directive. The intervention is the presence or absence of the masking directive in a hospital in each reporting month. The primary outcome is the monthly incidence of hospital-acquired acute viral respiratory infection (HA-VRI) among patients. Secondary outcomes include number and size of VRI outbreaks in acute care hospitals, healthcare worker absenteeism due to VRI, and healthcare system measures (e.g. isolations). Potential confounders will be accounted for in the analysis (e.g. community-level respiratory virus testing, healthcare worker vaccination rates, facility location and acuity levels). Descriptive analysis will include summary statistics, plots, and before-after comparisons. Model-checking techniques and sensitivity analyses will be done to test the robustness of the results. All analyses will be prespecified in a statistical analysis plan. Results In total 110 acute care hospitals were eligible to implement the enhanced masking directive during the study period. Preliminary numbers show that 31 of them enforced the directive at least once as of December 19, 2024. Ethics and data disclosure agreements were completed December 3, 2024, and data acquisition has begun. Regularly scheduled meetings with data custodians and analysts are ongoing. A provincial research advisory committee, which includes local knowledge users and patient partners are engaged in the project to support integrated knowledge translation. Analysis for the 2023/2024 respiratory period is anticipated to begin in March 2025. Conclusions With the implementation of the enhanced masking directive in Alberta during the 2023-2024 respiratory season, and in the current 2024-2025 respiratory season, there is an opportunity to contribute to the evidence on the effectiveness and impact of this masking policy in healthcare settings, which will help guide infection prevention and control preparedness and direction for healthcare workers for future viral respiratory infection outbreaks and inevitable future pandemics. Editorial Comments: Accepted for poster presentation (protocol only). Pillar 2 - Interventions and Evidence 46 Viral cultures for assessing airborne transmission of SARs-CoV-2: a systematic review protocol Igho Onakpoya1, Carl Heneghan1, Susanna Maltoni2, Annette Pluddemann1, Sara Gandini3, Jon Brassey4, Elena Rosca5, Tom Jefferson1, John Conly6 1University Of Oxford, Oxford, UK; 2University Of Bologna, Bologna, Italy; 3European Institute of Oncology, Milan, Italy; 4Trip Database, Bristol, UK; 5Victor Babes University of Medicine and Pharmacy, Timisoara, Romania; 6University of Calgary and Alberta Health Services, Calgary, Canada BMC Proceedings 2026, 20(29):46 Editorial Comments: Accepted for Elevator Pitch and poster presentation. Pillar 3 - Practice and Policy. Currently published as a full manuscript and citation below:Onakpoya IJ, Plüddemann A, Rosca EC, Gandini S, Maltoni S, Brassey J, Jefferson T, Heneghan CJ, Evans DH, Conly JM. Viral cultures for assessing airborne infectiousness of SARS-CoV-2: a systematic review and meta-analysis. BMC Infect Dis. 2025 Dec 25;26(1):297. https://doi.org/10.1186/s12879-025-12430-z.” https://pubmed.ncbi.nlm.nih.gov/41449370/ Onakpoya IJ, Plüddemann A, Rosca EC, Gandini S, Maltoni S, Brassey J, Jefferson T, Heneghan CJ, Evans DH, Conly JM. Viral cultures for assessing airborne infectiousness of SARS-CoV-2: a systematic review and meta-analysis. BMC Infect Dis. 2025 Dec 25;26(1):297. https://doi.org/10.1186/s12879-025-12430-z.” https://pubmed.ncbi.nlm.nih.gov/41449370/ Onakpoya IJ, Plüddemann A, Rosca EC, Gandini S, Maltoni S, Brassey J, Jefferson T, Heneghan CJ, Evans DH, Conly JM. Viral cultures for assessing airborne infectiousness of SARS-CoV-2: a systematic review and meta-analysis. BMC Infect Dis. 2025 Dec 25;26(1):297. https://doi.org/10.1186/s12879-025-12430-z.” https://pubmed.ncbi.nlm.nih.gov/41449370/ 47 Protocol: benefits and harms of herbal medicines for preventing and treating acute respiratory infections: an overview of systematic reviews Igho Onakpoya1, Susanna Maltoni2, Elizabeth Thomas1, Elena Rosca3, Sara Gandini4, Annette Pluddemann1, Fariba Aghajafari5, Carl Heneghan1, John Conly6, Tom Jefferson1 1University of Oxford, Oxford, UK; 2Division of Research and Innovation, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy; 3Victor Babes University of Medicine and Pharmacy, Timisoara, Romania; 4European Institute of Oncology, Milan, Italy; 5University of Calgary, Calgary, Canada; 6University of Calgary and Alberta Health Services, Calgary, Canada BMC Proceedings 2026, 20(29):47 Objectives To critically appraise and evaluate the benefits and harms of herbal medications for management of acute respiratory infections (ARIs), using evidence from systematic reviews. Methods We will conduct electronic searches in MEDLINE, EMBASE, Cinahl, and the Cochrane library. We will also conduct searches of the grey literature. Our primary outcomes will include rates of infection, resolution of symptoms, duration of symptoms, and symptom severity. We will include systematic reviews that examine the benefits and harms of a single herbal medicine or combination herbal products. We will exclude reviews that assess the effectiveness of herbal medicines combined with conventional ones. Reviews that do not use objective instruments to report the results of interventions will also be excluded. We will extract the relevant data onto customized excel spreadsheets. Two reviewers will independently screen abstracts, determine study eligibility, and extract the data. We will use the AMSTAR-2 criteria to assess the reporting quality of included systematic reviews and use the standard criteria to rate the reporting quality of the primary studies. Results We will use summary tables to present the baseline characteristics and the results of the effects of the interventions. We will report the results of children and adults separately. We will also report the results of reviews of prevention and treatment separately. We will use tables to present the quality of outcomes. Conclusions We will provide a summary of our overall findings and provide recommendations for or against the use of herbal medicines for specific ARIs. We will compare the findings of the overview with published research and enumerate its strengths and limitations. We will discuss the clinical implications of the review results, identify the gaps in evidence and suggest areas to prioritize for future research. Editorial Comments: Accepted for poster presentation. Pillar 2 - Interventions and Evidence 48 Evidence from Alberta - how hospital-based respiratory surveillance adapted through the COVID-19 pandemic Jennifer Ellison1, Blanda Chow2, Zhe Lu3, Christian Tsang2, Yi Fan Wu3, Kathryn Bush4 1Alberta Health Services, Lethbridge, Canada; 2Alberta Health Services, Calgary, Canada; 3Alberta Health Services, Edmonton, Canada; 4Interior Health, Kelowna, Canada BMC Proceedings 2026, 20(29):48 Objectives In today’s highly interconnected world, pathogens can cross borders more easily than ever before. Surveillance helps detect emerging pathogens early, reducing the time it takes to identify potential outbreaks and their sources. In early 2020, Infection Control (IC) programs worldwide were challenged with the COVID-19 pandemic and as it evolved, these programs continued to adapt and change. Evidence from Alberta shows how its robust IC program learned and adapted through the pandemic and continued to provide high quality surveillance information for action. Methods In early April 2020 and in partnership with the Canadian Nosocomial Infection Surveillance Program, the Alberta IC program rapidly launched a provincial protocol to capture lab-identified COVID-19 cases hospitalized in acute care facilities across Alberta. Standardized classifications were applied to identify cases that were likely hospital-acquired within Alberta, within long-term care, or in the community. In addition, 30-day adverse outcomes, including: death, intensive care unit (ICU) admission and mechanical ventilation, were assessed. The rigor of this protocol was strengthened as the surveillance team informed and met regularly with the data collectors to confirm protocol interpretations. Additionally, routine data linkages were conducted to assess data completeness and accuracy. As the pandemic evolved, additional metrics, including vaccination status and COVID-19 variant strain, were incorporated into surveillance. With COVID-19 becoming endemic and other respiratory viruses re-emerging, respiratory virus surveillance became more inclusive, focusing on all hospital-acquired viral respiratory pathogens in January 2023. Results Surveillance findings identified eight COVID-19 waves, with the last 4 waves representing various spikes in the Omicron variant. ICU admissions and deaths peaked in September 2021 at the height of the Delta wave, but hospitalized cases peaked in early 2022, during the first Omicron wave. From April 2023 – March 2024, COVID-19 continued to be the dominant hospital-acquired respiratory virus, peaking in the first week of October 2023 with a rate of 28/10,000 patient-days. Influenza A was the second most common, peaking in December 2023 with a rate of 9/10,000 patient-days. Most hospital-acquired viral respiratory infections were seen in patients over the age of 60, although pediatric patients saw more Enterovirus-Rhinovirus infections. Patients 65 years old or older continued to have a higher chance of dying within 30 days after acquiring COVID-19, Enterovirus-Rhinovirus, Influenza A, or Respiratory Syncytial Virus within hospital. Conclusions In a landscape of evolving pathogens, flexible, robust surveillance systems are essential. Alberta’s experience underscores the importance of adapting surveillance definitions, metrics, and outcomes to address shifting epidemiological trends, while maintaining data quality and ensuring preparedness for future respiratory virus outbreaks. Editorial Comments: Accepted for poster presentation. Pillar 3 - Practice and Policy 49 Rapid acceleration of digital health technologies in a pandemic: a double-edged sword Rosie Cooper1,2, Matthew Kurien3, Steven Ariss3, Geoff Wong1 1University of Oxford, Oxford, UK; 2NHS England, Oxford, UK; 3University of Sheffield, Sheffield, UK BMC Proceedings 2026, 20(29):49 Objectives The COVID-19 pandemic resulted in the need for physical distancing to prevent potential transmission. As a result, healthcare delivery which was often face-to-face was disrupted and delayed for numerous patients. Posited as a solution to this problem, healthcare policy widely advocated for non-pharmaceutical interventions (NPIs) in the form of digital health technologies (DHTs); accordingly, many healthcare systems accelerated DHT implementation, often with little evidence around their effectiveness. The findings presented here are a truncated part of a larger study which comprised a realist evaluation of coeliac disease (CD) DHTs. The objectives of this abstract are to:Present a novel understanding of the extent to which rapid implementation of NPIs, in the form of DHTs for coeliac disease, may result in successes, failures and unintended consequences; and Provide evidence which can be used to inform policy and care decisions around use of DHTs during public health emergencies. Present a novel understanding of the extent to which rapid implementation of NPIs, in the form of DHTs for coeliac disease, may result in successes, failures and unintended consequences; and Present a novel understanding of the extent to which rapid implementation of NPIs, in the form of DHTs for coeliac disease, may result in successes, failures and unintended consequences; and Provide evidence which can be used to inform policy and care decisions around use of DHTs during public health emergencies. Provide evidence which can be used to inform policy and care decisions around use of DHTs during public health emergencies. Methods To meet the above objectives, we employed a realist evaluation approach. A strength of this methodology means that the results have the potential to be applicable beyond CD to DHTs for many chronic conditions. Thus, the implications of this study may extend more widely to implementation of a range of NPIs in the form of DHTs in a healthcare emergency. As part of a realist evaluation, realist interviews were conducted with 40 seldom-heard individuals with CD around the use of DHTs. Participants were recruited purposefully and comprised individuals who were; digitally excluded; living with multimorbidity; from low socioeconomic status and from black and minority ethnic communities. Results Successes: Our data analysis found that many individuals with CD did not receive post-diagnosis care. This may have resulted from the need for physical distancing during the pandemic. In this way, CD DHTs may be able to improve access to healthcare, which may be of even greater importance during a health emergency. However, our findings suggest DHTs may widen existing inequalities and generate new inequalities. Our analysis suggests that individuals with CD and multimorbidity, or from black and minority ethnic communities are particularly at risk of this. We found using observable characteristics e.g. low socioeconomic status, ethnic minority, older age, poor digital literacy are not helpful in trying to predict for whom DHTs won’t work. Instead, characteristics of compatibility, relative advantage and complexity from Everett Rogers’ theory of the Diffusion of Innovations may be more useful ways to determine if a DHT is likely to be accessed and adopted. Conclusions To reduce future disruption, the pandemic highlighted the importance of developing and integrating digital healthcare. We found DHTs may have been successful in providing access to healthcare in a way that met social distancing requirements, however failures and unintended consequences may result in the form of widening existing inequalities and generating new inequalities. Our findings suggest that when developing and implementing DHTs, considering Rogers’ characteristics of compatibility, relative advantage and ease-of-use may be most useful in reducing failures and unintended consequences linked to inequalities. In other words, to reduce digital healthcare inequalities, our findings suggest consideration of these three characteristics may improve access and adoption, thus reducing digital healthcare inequalities. Editorial Comments: Accepted for poster presentation. Pillar 2 - Interventions and Evidence 50 Benefits and harms of remdesivir for COVID-19 in adults: early steps in a systematic review with meta-analysis of pivotal clinical trials Marc Chrétien, Igho Onakpoya University of Oxford, Oxford, UK BMC Proceedings 2026, 20(29):50 Objectives Remdesivir, a nucleotide inhibitor, is widely used for treatment of COVID-19 infection. Pivotal phase III trials have been used by drug manufacturers to gain marketing approval for remdesivir. Several reviews have been published evaluating the effectiveness of remdesivir. However, there have been no reviews of the benefits and harms of remdesivir based on information in pivotal trials. In this project I aim to critically appraise and summarize the evidence for benefits and harms of remdesivir therapy for COVID-19 illness in adults using evidence from pivotal clinical trials. Primary outcomes will include changes in mortality and serious adverse events. Secondary outcomes will include length of hospital stay, time to death hospitalizations, and overall adverse events. Methods We conducted searches across drug regulatory websites including European Medicines Agency (EMA), Food and Drug Administration (FDA), Medicines & Healthcare products Regulatory Agency (MHRA), Health Canada (HC), Therapeutic Goods Administration (TGA), and Pharmaceuticals and Medical Devices Agency (PMDA) and bibliographic databases (PubMed, Embase). We explored grey literature, backward and forward reference searching, and contacted corresponding authors of journal publications for additional data when needed. Henceforth we will extract primary and secondary data from included trials according to study type, and setting, participant characteristic(s), study duration, and effects of interventions and will assess the risk of bias using the Cochrane criteria and RoB 2 tool. Randomized participants who received at least one dose of medication will be included in a meta-analysis. I2 values will be used to assess heterogeneity. Sensitivity analyses and subgroup analyses will be used to test the robustness of the overall analyses. Results We designed a search protocol and published on Open Science Framework. Searches across drug regulatory websites showed 4, 3, 5, 4, 6, and 2 studies from EMA, FDA, MHRA, HC, TGA, and PMDA drug regulatory websites, respectively. In total there were seven independent studies. We will search each study in PubMed and Embase for related publications, screen for inclusion/exclusion criteria, and extract data for meta-analysis. Conclusions Results from this systematic review with meta-analysis will provide an evidence-based summary to clinicians, public policy experts, and health economists on the benefits and harms of remdesivir therapy in COVID-19 positive adults from pivotal trials. Editorial Comments: Accepted for oral abstract presentation. Pillar 2 - Interventions and Evidence (data challenges/other)